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Oxidative stress has been implicated as playing a role in neurodegenerative 
disorders, such as ischemic stroke, Alzheimer’s, Huntington’s, and Parkinson’s disease. 
Persuasive evidences have shown that microglial-mediated oxidative stress contributes 
significantly to cell loss and accompanying cognitive decline characteristic of the 
diseases. Based on the facts that (i) levels of catalytically active myeloperoxidase are 
elevated in diseased brains and (ii) myeloperoxidase polymorphism is associated with the 
risk of developing neurodegenerative disorders, HOCl as a major oxidant produced by 
activated phagocytes in the presence of myeloperoxidase is therefore suggested to be 
involved in neurodegeneration. Its association with neurodegeneration is further showed 
by elevated level of 3-chlorotyrosine (bio-marker of HOCl in vivo) in affected brain 
regions as well as HOCl scavenging ability of neuroprotectants, desferrioxamine and uric 
acid. Therefore, primary mouse cortical neurons treated with HOCl were employed to 
investigate the mechanistic insight of HOCl on neuronal cell death. The current study 
reports for the first time that HOCl mediates concentration-dependent apoptosis-necrotic 
continuum neuronal cell death. Neurotoxicity caused by intermediate concentration of 
HOCl (250 μM) exhibited ATP depletion and several biochemical markers of apoptosis 
in the absence of caspase activation. Yet, the involvement of calpains was demonstrated 
by data showing that calpain inhibitors protect cortical neurons from apoptosis and the 
formation of 145/150 kDa α-fodrin fragments. Further, elevation of cytosolic calcium 
concentration was observed and calcium channel antagonists and EGTA prevented 
cleavage of α-fodrin and the induction of apoptosis. Finally, calpain activation causes the 
onset of lysosomal pathway. With the aid of DNA microarray, orphan nuclear receptor 
 ix
Nr4a1 that engaged in caspase-independent cell death was up-regulated nearly 10 folds 
after 8 h of treatment. In addition, three survival mechanisms such as suppression of cell 
cycle genes, induction of NF-E2-related factor-2-antioxidant response element (Nrf2-
ARE) pathway and down-regulation of genes involved in energy-dependent processes 
were identified at gene expression level. In conclusion, the present study proposes that 
HOCl triggers caspase-independent apoptosis by activating redox sensitive calcium 
channels e.g. L-type channel, ryanodine receptor and IP3 receptor leading to increase of 
intracellular calcium concentration and subsequent activation of calpain and release of 
cathepsins from destabilized lysosomes. Elevated calcium level also induces the 
expression of Nr4a1 which transmits apoptotic signalling from nucleus to mitochondria 
and causes concomitant release of mitochondrial cell death mediators. The participation 
of calpain, cathepsins, Nr4a1 and defense mechanisms in the neurotoxicity of HOCl 
enables them to be targeted for multiple disorders which HOCl is found associated. As a 
result, this study might offer a novel potential therapeutic area for multiple sclerosis, 
Parkinson’s and Alzheimer’s diseases and probably allow clinical research to mature 
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1.1 NEURONS DIE BY APOPTOSIS IN NEURODEGENERATIVE DISORDERS 
 
The process of neuronal death is of particular relevance since, from the fetal stage, 
most of the neurons are post-mitotic, meaning that a cellular loss cannot be replaced by de 
novo neuronal proliferation. An important instance of neuronal death is during the 
developmental stage. Initially, there is an overproduction of neuronal cells, followed by a 
second stage in which the excesses to requirements are let, or forced, to disappear 
(Davies, 2003). The other general instance is during neuropathological conditions such as 
Alzheimer’s disease (AD), multiple sclerosis (MS), Parkinson’s disease (PD), 
Huntington’s disease (HD) and amyotrophic lateral sclerosis (ALS) in which nervous 
system functionality is decreased owing to the death of neurons (Ekshyyan and Aw, 
2004).  
 
1.1.1 Types of cell death: apoptosis and necrosis 
Mammalian cells can die by one of several different defined pathways, the most 
common of which are apoptosis and necrosis. The ancient Greek word apoptosis, which 
refers to the falling of leaves off a tree, was used by Kerr et al. (1972) to describe cell 
deaths seen in the absence of any pathology. It serves many critical functions, such as cell 
deletion during embryonic development, balancing cell numbers in continuously renewing 
tissues, hormone-dependent involution in the adult, immune system development, 
selective immune cell deletion, and many other physiologic processes (Majno and Joris, 
1995; Yuan and Yankner, 2000). The purpose is to remove unnecessary, aged or damaged 
cells. Therefore, this is a process in which cells play an active role in their own death. 
Apoptosis describes cell death morphologically by cell shrinkage, plasma condensation, 
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and membrane blebbing, followed by cell fragmentation and formation of membrane 
vesicles called apoptotic bodies. In vivo, these apoptotic bodies with phosphatidylserine 
(PS) on the outer leaflet of the plasma membrane serve as ‘eat me’ signal are rapidly 
taken up by either macrophages or epithelial cells and thus no inflammatory response in 
evoked (Yuan and Yankner, 2000).  
In contrast, necrosis, also called pathological cell death, refers to morphological 
changes like early loss of plasma membrane integrity, cell swelling, and early changes to 
the organelles. Due to the ultimate breakdown of the plasma membrane, the cytoplasmic 
contents including lysosomal enzymes are released into the extracellular space resulting in 
extensive tissue damage and inflammatory responses (Majno and Joris, 1995). Features of 
necrosis and apoptosis are summarized in table 1.1.  
 
Table 1.1: Comparison of the features of necrosis and apoptosis.  
Necrosis Apoptosis 
Stimuli include toxins, severe hypoxia, 
massive insult, and conditions of ATP 
depletion. 
 
Stimuli include physiological and 
pathological conditions without ATP 
depletion. 
No energy requirement. 
 
ATP dependent. 
Affects large numbers of contiguous cells. 
 
Affects scattered individual cells. 
Cell swells; organelles swell; disruption of 
organelles occurs. 
 
Cell shrinks; chromatin condenses; 
apoptotic bodies form. 
Random degradation of DNA. 
 
Internucleosomal DNA breakdown. 
Plasma membrane is lysed. Plasma membrane remains intact and 
blebbed. 
 




1.1.2 Apoptosis – a feature of neurologic diseases 
The involvement of apoptosis in neurodegenerative disorders was demonstrated 
with the detection of DNA cleavage in neuronal nuclei of post-mortem brain tissue. There 
were significantly elevated number of cells with DNA fragmentation in postmortem 
analysis of patients with AD, PD, HD, and ALS (Su et al., 1994; Dragunow et al., 1995; 
Lassmann et al., 1995; Li et al., 1997; Lucassen et al., 1997; Sugaya et al., 1997). 
Furthermore, the up-regulation of Bax, p53, Fas, and Par-4 in AD brain supports the 
existence of pre-apoptotic neurons in neurodegenerative diseases (Nishimura et al., 1995; 
Anderson et al., 1996; Kitamura et al., 1997, 1998; Su et al., 1997; Guo et al., 1998). 
Other gene and protein changes that have been found in the post-mortem brains in 
neurodegenerative diseases and that support the notion that apoptosis has occurred include 
increased transglutaminase, the appearance of cyclin B, cyclin E, Cdc2 kinase and the 
cyclin-dependent kinase (Cdk) inhibitor p16, and an increase in p53 in cortical astrocytes. 
Increased caspase activities as well as cleavage of caspase substrates have also been 
detected in AD (Yang et al., 1998; Chan et al., 1999; LeBlanc et al., 1999; Stadelman et 
al., 1999; Uetsuki et al., 1999; Rohn et al., 2001; Pompl et al., 2003), cerebral ischemia 
(Rabuffetti et al., 2000; Kang et al., 2000; Benchoua et al., 2001), ALS (Martin, 1999), 
and HD (Sanchez et al., 1999; Kiechle et al., 2002).  
 Taken together, the evidence for nuclear changes typical of apoptosis and the 
finding of changes in the expression of apoptosis-related genes and their protein products 
makes it highly likely that apoptosis contributes to nerve cell loss in human 




1.1.3 Executioners of apoptotic cell death 
In a formal way, one can divide the events leading to apoptotic demise into three 
stages: signaling, activation, and commitment. In signaling stage, external or internal 
signals push the cells toward apoptosis then the enzymatic systems become fully primed 
for action in the subsequent activation stage. During the early phases of apoptosis, the 
neurons can still be saved from death, but not after the neurons enter the commitment 
stage in which two essential types of processes take place: (i) the activation of the 
genome, with resultant de novo protein synthesis; and (ii) the activation of a series of 
cytoplasmic and nuclear proteases. The roles of genomic activation are demonstrated by 
the fact that, in many instances, apoptosis triggered by a variety of inducers is prevented 
by protein synthesis inhibitors (Dragunow and Preston, 1995). In the final execution stage, 
various active proteases including caspases, calpains, and cathepsins cleave their specific 
substrates, resulting eventually in the morphological and functional changes characteristic 
for apoptosis.  
1.1.3.1 Caspases  
 Caspases are a family of cysteine proteases that cleave their substrates after 
aspartic residues and their activation has been identified as a hallmark of apoptosis. They 
are synthesized as inactive zymogens that are proteolytically cleaved into subunits at the 
onset of apoptosis and function as active caspases after reconstitution to molecular 
heterodimers. Caspases are composed of three domains including an N-terminal 
prodomain, a large subunit, and a small subunit (Earnshaw et al., 1999). As a result of 
their activation sequence, caspases are classified as either initiator caspases (also known 
as apical caspases) or effector caspases (Shi, 2002). Initiator caspases such as caspases 2, 
8, 9, and 10 are activated by the cell-death signal and have a long N-terminal prodomain 
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that regulates their activation (Hengartner, 2000; Shi, 2002). Once initiator caspases are 
activated, they activate downstream effector caspases 3, 6, and 7 (Hengartner, 2000; Shi, 
2002). Short prodomain containing effector caspases then mediate cell death by 
destruction of key cellular substrates and activation of machinery that degrades DNA (Liu 
et al., 1997; Enari et al., 1998; Sakahira et al., 1998; Friedlander, 2003).  
1.1.3.2 Calpains 
 Calpains are part of an intracellular family of cysteine proteases that are 
independent from caspases. At least 15 mammalian calpains have been identified, with 
two of these μ-calpain and m-calpain expressed primarily in the central nervous system 
(CNS). μ-Calpain and m-calpain are heterodimeric proteins with a large 70-80 kDa 
catalytic subunit and a 29 kDa regulated subunit. In the nervous system, μ-calpain is 
predominantly distributed in dendrites and the bodies of neurons while m-calpain is 
expressed in axons and in glia (Onizuka et al., 1995).  
 Calpain activation is initiated by calcium with limited autolysis (Moldoveanu et 
al., 2002). μ-Calpain has a relatively high binding affinity to calcium and is activated by 
micromolar concentrations (3-50 μM) of calcium, while m-calpain binds to calcium with 
lower affinity and requires a higher concentration of calcium (0.2-1 mM) for half-
maximal activity (Cong et al., 1989; Matsumura et al., 2001). Calcium, however, is not 
the only factor involved. The activity of calpains also is regulated by the endogenous 
inhibitor calpastatin and the state of phosphorylation (Goll et al., 2003).  
 Calpain activation leads to cell injury through the cleavage of substrates important 
for cellular architecture including α-fodrin, ankyrin, and neurofilament proteins (Goll et 
al., 2003). Calpain activation can also be a crucial step in the induction of apoptotic 
pathways by proteolytically activating Bax (Wood and Newcomb, 1998; Wood et al., 
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1998), decreasing antiapoptotic Bcl-2 proteins (Gil-Parrado et al., 2002) as well as 
facilitating the activation of caspase 3, 7, and 12 (Ruiz-Vela et al., 1999; Nakagawa and 
Yuan, 2000; Blomgren et al., 2001). On the other hand, calpains can block the activation 
of caspases. For example, calpains can cleave caspase 9 rendering it incapable of 
activating caspase 3 and preventing the subsequent release of cytochrome c (Chua et al., 
2000). Calpains are, at least in part, also associated with lysosomes (Yamashima et al., 
2003). 
Other than caspase, calpain has also been implicated in the loss of neurons of PD 
(Mouatt-Prigent et al., 1996; Crocker et al., 2003). Calcium and m-calpain levels are 
elevated (Grynspan et al., 1997; Tsuji et al., 1998), and autolysis of μ-calpain to its 76- 
and 78-kDa forms is enhanced (Saito et al., 1993) in brain tissue from patients with AD. 
There also evidences suggest that calpain activation is not simply a consequence of 
neurodegeneration but, instead, precedes and contributes to the neurodegenerative 
process. For example, the regulatory protein p35, which aids in the development of neural 
tissue, is cleaved by calpains in brain tissue from patients with AD into a 25-kDa form 
(p25), activating Cdk 5 that responsible for the hyperphosphorylation of tau in the 
intracellular neurofibrillary tangles in the brain of AD (Ahlijanian et al., 2000; Kusakawa 
et al., 2000).   
1.1.3.3 Lysosome and cathepsin proteases  
Lysosomes are present in the cytoplasm of all animal cell types. Originally, they 
are thought as involved only in the digestion of cell nutrients, cell protein turnover, tissue 
remodeling, lysis of invaders, and autolysis of dead cells. However, their role have been 
found to go beyond that of simple ‘garbage disposals’ and actively contribute to signaling 
pathways in oxidative stress-induced cell damage (Zdolsek et al., 1993; Antunes et al., 
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2001; Dare et al., 2001; Persson et al., 2003). The lysosomal pathway of apoptosis 
involves small-scale lysosomal leakage and subsequent release of lysosomal cathepsins 
into the cytosol (Brunk et al., 2001; Guicciardi et al., 2004; Jaattela et al., 2004). 
Lysosomal rupture can be induced indirectly by activation of phospholipase A2, 
which depends on the activation of Ca2+ signaling (Burlando et al., 2002). In addition, the 
proapoptotic members of the Bcl-2 family might translocate to the lysosomal membrane 
to induce membrane permeabilization (Kagedal et al., 2005). Besides extralysosomal 
signals, lysosomal cysteine protease can also participate to the process of membrane 
destabilization from within the lysosome (Werneburg et al., 2002). 
The lysosomal cysteine proteases (aka cathepsins) belong to the papain 
superfamily of cysteine proteases as calpains (Chapman et al., 1997). Cathepsins 
represent the largest group of proteolytic enzymes in the lysosomes. Among the 11 human 
cathepsins known (cathepsin B, H, L, S, F, K, C, W, X, V, and O), cathepsin B and L are 
ubiquitously expressed and are the most abundant in the lysosomes, together with 
cathepsin D, the only lysosomal aspartic protease (Turk et al., 2001). They are 
synthesized as inactive precursors and undergo proteolytic activation in the lysosomes 
(Ishidoh and Kominami, 2002). Cystatin C, a low molecular weight (13 kDa) protein, is a 
potent endogenous inhibitor of the cysteine proteases, including cathepsin B, L, H and S. 
Although lysosomal enzymes have an activity optimum at acidic pH, lysosomal cysteine 
proteases are stable and active at neutral pH for a time that ranges from a few minutes to 
an hour or more (Turk et al., 1995, 2000).  
The accumulation of lysosomes and their hydrolases within neurons is a well-
established neuropathologic feature of AD (Cataldo et al., 1991; Nixon et al., 2000; 
Nakanishi, 2003). Cathepsin B and L are lysosomal proteinases that are found 
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extracellularly at high levels in the senile plaques of AD brain (Cataldo and Nixon, 1990). 
Study on Aβ-mediated neuronal apoptosis showed that the activity of cathepsin L and its 
cytosolic expression are increased (Boland and Campbell, 2004). Elevated levels of the 
lysosomal enzyme cathepsin D are also observed in cortical and hippocampal neurons and 
co-occur with intraneuronal tangles, indicating its association with neurodegeneration in 
AD (Cataldo et al., 1997). In addition, cathepsin S is upregulated in AD brain too (Lemere 
et al., 1995). It is also involved in the generation of Aβ in the endosomal/lysosomal 
compartment (Munger et al., 1995). Cathepsin B involvement has also been reported in 
motor neuron degeneration of ALS (Kikuchi et al., 2003). Overexpression of huntingtin 
protein in cultured cells induces elevated expression of cathepsin D in vacuoles that 
expressed huntingtin (Kegel et al., 2000). Transient ischemia also dynamically affects the 













1.2 OXIDATIVE STRESS AND NEURODEGENERATIVE DISEASES—
PHAGOCYTES CONTRIBUTION 
 
Oxidative stress refers to an imbalance between the intracellular productions of 
reactive oxygen species (ROS) and the cellular defense mechanisms (Halliwell and 
Gutteridge, 1999). ROS may be derived from environmental sources or maybe generated 
de novo within tissues as a consequence of the intracellular metabolism. On the other 
hand, cellular defense mechanisms comprise antioxidant enzymes operate in concert with 
non-enzymatic, low-molecular-weight antioxidant compounds to maintain redox 
homeostasis as well as metal-binding proteins that maintaining transition metals in a 
relatively low redox state.  
Several cellular features of the brain suggest that it is highly sensitive to oxidative 
stress (Halliwell and Gutteridge, 1999). For example, the brain is known to possess the 
highest oxygen metabolic rate of any organ in the body. In addition, the brain tissues have 
high content of unsaturated fatty acids that can be metabolized by oxygen free radicals. 
Furthermore, the brain contains high level of iron which have been associated with free 
radical injury. Yet, the level of antioxidant and antioxidant enzymes in the brain are 
significantly below other body organs.  
Although it is still unclear whether oxidative stress is the cause or consequence of 
apoptotic cell death in neurodegenerative disorders, a growing body of evidence 
implicates it as being involved in at least the propagation of cellular injury that leads to 
neuropathology in these various conditions (Jenner, 2003; Andersen, 2004; Emerit et al., 
2004). Phagocytes, particularly microglia, are a major source of oxidizing radicals in brain 
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(Colton and Gilbert, 1993). Therefore, oxidants produced by phagocytes are implicated as 
critical components of oxidative insult to neurons. 
 
1.2.1 Evidences of oxidative stress in neurodegenerative diseases 
1.2.1.1 Elevation of oxidized biomolecules 
The oxidation and nitration product of biomolecules have been reported in 
diseased brains. Double bond of unsaturated fatty acids, such as linoleic acid and 
arachidonic acid, are particularly susceptible to oxidative modification. The end products 
of lipid oxidation including 4-hydroxy-2,3-nonenal (HNE), acrolein, malondialdehyde and 
F2-isoprostanes. Elevated HNE levels have been observed in AD (Butterfield et al., 2002; 
Selley et al., 2002), PD (Dexter et al., 1989) brain tissues, while increased HNE has been 
observed in the cerebrospinal fluid (CSF) of ALS patients (Pedersen et al., 1998). The 
remaining breakdown products were too found increased in AD, PD and ALS patients 
(Dexter et al., 1989; Sayre et al., 2001; Arlt et al., 2002). All four bases of DNA are 
susceptible to oxidative damage involving hydroxylation. Increased oxidative damage of 
nuclear and mitochondrial DNA has been reported in AD (Gabbita et al., 1998; Wang et 
al., 2005).  Increased levels of 8-hydroxyguanine and 8-hydroxy-2-deoxyguanosine are 
also observed in PD brains (Alam et al., 1997). In case of protein, its oxidation can lead to 
formation of protein carbonyl and nitration of tyrosine residues resulting in protein 
crosslinking and deposition. Tyrosine nitration is found in AD brains (Castegna et al., 
2003), in the plaques of MS brains (Bagasra et al., 1995), and in degenerating upper and 
lower motor neurons in ALS patients (Beal et al., 1997). Selective oxidative modification 
of intracellular proteins, such as increased protein carbonyl levels in creatine kinase and 
β-actin in AD brains support a role for oxidative stress during neurodegeneration 
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(Aksenov et al., 2000, 2001). Protein carbonyl level also increase in patient with motor 
neuron disease as compared to control subjects (Shaw et al., 1995). In addition, 
neurodegenerative diseases are often associated with protein aggregates such as Aβ and 
inclusion bodies. Modification of sugars marked by increased glycation and glycoxidation 
are also observed in neurodegenerative disorders (Sasaki et al., 1998; Shibata et al., 2001; 
Moreira et al., 2005; Pamplona et al., 2005).  
1.2.1.2 Changes of endogenous defense mechanisms 
Intracellular oxidative balance is tightly regulated so that changes in endogenous 
defense mechanisms would be expected in the face of stress for cells to adapt and survive 
and changes in these are also used as markers of oxidative stress. Cellular defenses against 
free radicals include enzymatic and non-enzymatic mechanisms. Non-enzymatic 
antioxidant defenses include tri-peptide glutathione (γ-glutamyl-cyteinyl-glycine) (GSH), 
ascorbic acid (vitamin C) and α-tocopherol (one of the vitamin E family). The enzymatic 
defenses include superoxide dismutase (SOD), catalase, and glutathione peroxidase 
(GSH-Px). Collectively, these enzymes provide a defense against superoxide radical (O2.-) 
and hydrogen peroxide (H2O2). SOD converts O2.- to H2O2 which is further metabolized 
by GSH-Px generating H2O and oxidized GSH (GSSG) or is dismutated directly by 
catalase. Toxic compounds generated by the interaction of ROS with macromolecules are 
detoxified by enzymes such as glutathione S-transferase (GST) (Masella et al., 2005). 
In AD brain, mRNA level of oxidative stress-handling genes for instance SOD, 
catalase, GSH-Px and glutathione reductase are elevated (Aksenov et al., 1998). The 
activity of the antioxidant proteins catalase, SOD, and GSH-Px are increased in the 
hippocampus and amygdale (Zemlan et al., 1989; Pappolla et al., 1992). Impaired 
glutathione metabolism is also presented for AD and ALS (Bains and Shaw, 1997). 
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Reductions in GSH levels in the substantia nigra have also been reported. Another index 
of oxidative stress is the activation of the transcriptional factor, nuclear factor-kappa B 
(NF-kB). A lot of evidences indicate that ROS can act as second messengers mediating 
activation of NF-kB, which in turn influence the expression of a large number of genes 
including SOD to dampen an excessive accumulation of ROS (Rojo et al., 2004). 
Increased levels of NF-kB have been reported in vulnerable regions of the CNS of AD, 
PD and ALS (Kaltschmidt et al., 1997). Immunohistochemical analysis of brain sections 
from AD patients showed activated nuclear form of NF-kB in neurons and astrocytes. The 
nuclei of dopaminergic neurons in the substantia nigra of PD patients also have a robust 
increase of NF-kB.  
 
1.2.2 Phagocytes are mediators of oxidative stress  
 Phagocytes are the main source of oxidants in vivo. Generation of free radicals by 
phagocytes has been demonstrated in vitro using monocytes/macrophages and microglia 
from humans and rodents stimulated with amyloid-β (Aβ) (Klegeris et al., 1994; Meda et 
al., 1996; Van Muiswinkel et al., 1996, 1999; Klegeris and McGeer, 1997; McDonald et 
al., 1997). Microglia represent the largest population of phagocytes associated with CNS. 
Microglia are monocyte-derived immunocompetent cells that enter the CNS during 
embryonic development and display a quiescent phenotype. Normally the microglia are 
few in number, but they multiply in response to virtually any pathological events in the 
CNS (Benveniste, 1997). Microglial cells are associated with virtually every AD and PD, 
MS lesions (McGeer et al., 1987, 1988; Dickson et al., 1993; Banati et al., 2000) and 
exhibit a reactive phenotype (Miyazono et al., 1991). There is compelling evidence that β-
amyloid as stimuli to provoke a microglial-mediated inflammatory response that 
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contributes significantly to neuronal loss and cognitive decline in AD (McGeer et al., 
1987; Itagaki et al., 1989; Selkoe, 1991; Giulian et al., 1996; Frautschy et al., 1998; Geula 
et al., 1998; Weldon et al., 1998; Bornemann et al., 2001). Epidemiological studies show 
a lower than expected prevalence or delayed onset of AD in patient populations using 
non-steroidal anti-inflammatory drugs (NSAIDs) treatment (McGeer et al., 1996), which 
was associated with less microglial activation (Mackenzie and Munox, 1998; Combs et 
al., 2000). The role of microglia in MS is also supported in the MS animal model where 
microglia are shown to proliferate and increase lysosome activity around active sites of 
demyelization (Matsumoto et al., 1992). Microglia and neurodegeneration have been 
implicated in numerous other diseases, such as hypoxia (Olson and McKeon, 2004), 
stroke (Morioka et al., 1993), ALS (Banati et al., 1995), and neuropathic pain (Tsuda et 
al., 2004). In most pathological settings microglia are aided by infiltrating macrophages 
(Stollg and Jander, 1999), which serve a similar function with them. These studies 
collectively support the concept that phagocytes activation is an important component of 
neurodegeneration.  
 
1.2.3 Oxidants generated by activated phagocytes 
Phagocytes generate oxidants by the action of four enzymes: reduced nicotinamide 
adenine dinucleotide phosphate (NADPH) oxidase, SOD, nitric oxide synthase (NOS) and 
myeloperoxidase (MPO) (Fig. 1.1). NADPH oxidase, a latent electron transport chain 
found on the plasma membrane of phagocytes, is activated during phagocytosis leading to 
production of O2.- (Vignais, 2002).  
2 O2 + NADPH Æ 2 O2.- + NADP+ + H+ 
 15
O2.-, having one unpaired electron, is highly reactive and reacts rapidly with neighboring 
O2.- radicals at a rate of ~5×105 M-1.sec-1 (at neutral pH; Halliwell and Gutteridge, 1999) 
to form H2O2 spontaneously via dismutation. 
 2 O2.- + 2 H+ Æ 2 H2O2 
This reaction could also be accelerated catalytically by the SOD. Neither O2.- and H2O2 is 
particularly toxic as they react rather sluggishly with many biologically important 
compounds. Cells can greatly enhance the toxicity of O2.- by producing NO through the 
action of NOS. Increased expression of inducible NOS is found in microglia at sites of 
lesion in MS (Hill et al., 2004). O2.- and NO react together to form ONOO- (Saran et al., 
1990; Koppenol et al., 1992). In the presence of carbon dioxide, ONOO- reacts readily 
with proteins to form nitrotyrosine. Although human mononuclear phagocytes can express 
iNOS when appropriately stimulated, NO production by these cells is very low as 
compared with mouse phagocytes (Albina, 1995; Weinberg et al., 1995). As a result, the 
reaction of NO with O2.- to form ONOO- will not be so plauserable in human phagocytes.  
On the other hand, the toxicity of H2O2 is enhanced by the activity of MPO. H2O2 
that formed becomes a substrate for MPO released from primary granules subsequent to 
their fusion with the phagocytic vacuole. MPO is a heme protein that accounts for 5% of 
the total neutrophil protein. In combination with H2O2, MPO can oxidize the halides and 
the pseudohalide thiocyanate (SCN-) to their corresponding hypohalous acids (Babior, 
2000).  
 H2O2 + X- + H+ Æ HOX + H2O  (X- = Cl-, Br-, I- or SCN-) 
Owing to its high concentration in biological fluids (100-140 mM Cl-, 20–100 µM 
Br-, <1 µM iodide, 20-120 μM SCN-; ref. Wood, 1975; Holzbecher and Ryan, 1980), Cl- 
is the major substrate for MPO; consequently, HOCl is the oxidation product. Up to 80% 
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of the H2O2 generated by activated neutrophils is used to form 20-400 μM HOCl an hour 
(Weiss et al., 1982; Foote et al., 1983; King et al., 1997; Babior, 2000; Hussien et al., 
2002). One exception to this generalization is saliva which contains 103 M SCN- 
(Pettigrew and Fell, 1972). Unlike HOCl, HOSCN is not harmful to mammalian cells and 
is not considered a toxicant (Slungaard and Mahoney, 1991). Alternatively, H2O2 can also 
be converted to highly reactive OH. via Fenton and Haber-Weiss reactions. Even though 
OH. is commonly discussed in textbooks as generated by Fenton and Haber-Weiss 
reactions, their formation by these reactions is too slow. Most importantly MPO limits the 
reaction further by consuming H2O2 for HOCl production. The reactions of HOCl with 
O2.- and ferrous iron which are analogous to Haber-Weiss and Fenton reactions but are at 
least several orders of magnitude faster will be the likely route for .OH formation in brain 
(Candeias et al., 1993, 1994). Evidence for the occurrence of this reaction in neutrophils 
and eosinophils has been reported (Ramos et al., 1992). HOCl can react with nitrite 
(breakdown product of NO metabolism) to generate a less cytotoxic product nitryl 
chloride, NO2Cl possessing oxidizing, chlorinating and nitrating ability (Eiserich et al., 
1996; Whiteman et al., 2002). Nitrite levels in healthy subjects have been reported as 
around 1 μM in CSF and increased levels have been reported in diseased brains 
(Yamashita et al., 1997; Krupinski et al., 1998; Taskiran et al., 2000; Yuceyar et al., 
2001). Therefore, HOCl as a major oxidant formed by phagocytes in the presence of MPO 
contributes to both oxidative and nitrative processes by the production of secondary 
species, OH. and NO2Cl. Additionally, the neuroprotective effects of desferrioxamine and 
uric acid has been demonstrated of their HOCl scavenging ability (Kaur and Halliwell, 
1990; Becker, 1993). Based on the evidences, HOCl appears as the center of the 
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pathogenic mechanism that leads to neurodegeneration. However, little attention has been 





































Figure 1.1: Oxidants generated by activated phagocytes.  
 
Phagocytes produce oxidants by four enzymes. NADPH oxidase reduces O2 to O2.- which 
is in turn converted to H2O2 by SOD. Neither O2.- and H2O2 are particularly toxic. Cells 
enhance the toxicity of O2.- by producing NO via the action of NOS. These two radicals 
can react together to form ONOO-, a nitrating agent. However, the production of NO in 
human phagocytes is uncertain. The toxicity of H2O2 is enhanced by MPO which 
consumes most of the H2O2 generated to form HOCl and makes the production of OH. 
from H2O2 via the slow Fenton and Haber-Weiss reactions unlikely. In fact, HOCl can 
react with O2.- and ferrous iron to form OH.. Another secondary reactive species, NO2Cl, 
is generated by the reaction of HOCl between the end-product of NO metabolism. 
Therefore, the presence of MPO favours the production of HOCl and concomitant 
formation of OH. and NO2Cl. Red arrows represent the most likely route for oxidants 





















1.3 HOCl: AN UNDER APPRECIATED MEDIATOR OF 
NEURODEGENERATION 
 
HOCl is a weak acid, with a pKa of approximately 7.53 (Morris, 1966). Hence 
HOCl is about 50% ionized at pH 7.4.  
HOCl ÅÆ H+ + OCl- 
Hypochlorite (OCl-) absorbs light at 292nm (molar extinction coefficient, ε = 350  
dm3mol-1cm-1) and so concentrations of HOCl can easily be determined by adding alkali 
and reading the absorbance, or by adding acid and reading the absorbance of HOCl at 
235nm (ε = 100 dm3mol-1cm-1) (Halliwell and Gutteridge, 1999). However, for the sake of 
brevity the effects of HOCl will be discussed without distinguishing between those effects 
that are or may be due to either the acidic or anionic forms of the molecule in the 
subsequent chapters.  
 
1.3.1 Evidences for HOCl as a mediator of neurodegeneration 
1.3.1.1 PD 
PD is a common neurodegenerative disorder characterized by disabling motor 
abnormalities, which include tremor, muscle stiffness, paucity of voluntary movements, 
and postural instability (Dauer and Przedborski, 2003). Its main neuropathological feature 
is the loss of the nigrostriatal dopaminergic neurons, the cell bodies of which reside in the 
substantia nigra pars compacta (SNpc) and nerve terminals of which extend to the 
striatum (Dauer and Przedborski, 2003). Except for a handful of inherited cases related to 
known gene defects (Vila and Przedborski, 2004), PD is a sporadic condition of unknown 
pathogenesis (Dauer and Przedborski, 2003). However, epidemiological studies suggest 
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that inflammation increases the risk of developing PD (Chen et al., 2003), and 
experimental models of PD show that microglial activation modulates SNpc dopaminergic 
neuronal death and blockage of the activation is neuroprotective (Gao et al., 2002; Wu et 
al., 2002). NADPH oxidase is found upregulated in damaged areas in both PD and the 1-
methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model of PD (Wu et al., 2003). 
Recent study also showed that the level of MPO expression increases markedly in 
diseased SNpc from both mice exposed to MPTP and human PD (Choi et al., 2005). 
Therefore, neurons located in the damaged area might have been subjected to the 
deleterious effects of MPO/H2O2/Cl- system. High levels of 3-chlorotyrosine and HOCl-
modified protein in MPTP-susceptible brain region further support the oxidative role of 
HOCl in PD (Choi et al., 2005).  
1.3.1.2 AD 
AD is the most common form of age-related cognitive failure in humans. It is 
characterized neuropathologically by the progressive accumulation of the neuritic plaques 
composed of aggregates of Aβ protein, a 40-43 amino acid proteolytic fragment derived 
from the amyloid precursor protein. These plaques are associated with dystrophic neuritis 
(altered axons and dendrites), activated microglia and reactive astrocytes. MPO presence 
have been demonstrated in microglia and neurons associated with AD plaques (Reynolds 
et al., 1999; Green et al., 2004). In vitro studies show that Aβ can promote the assembly 
of active NADPH oxidase and MPO in microglia, macrophages, neutrophils, astrocytes 
and neurons (Reynolds et al., 1999; Jana and Pahan, 2004; Abramov and Duchen, 2005) 
and could, therefore, stimulate generation of HOCl in the brain. Functional polymorphism 
in the MPO gene has been found to be associated with increased risk for AD (Reynolds et 
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al., 1999). The elevated level of 3-chlorotyrosine in AD brain again supports that HOCl is 
produced during the progression of AD (Green et al., 2004).   
1.3.1.3 Cerebral ischemia 
Cerebral ischemia arises from severe reductions in cerebral blood flow due to 
obstruction of blood flow in a major cerebral vessel (usually the middle cerebral artery), 
cardiac arrest, or periods of prolonged systemic hypotension. Upon the reduction of blood 
flow, there is a disruption in glucose and oxygen supply to the neurons as well as build-up 
of potentially toxic substances. The deprivation in glucose and oxygen delivery can result 
in the reduction in metabolites such as ATP, leading to metabolic stress, energy failure, 
ionic perturbations, activation of microglia and astrocytes, and neuronal death (Siesjo et 
al., 1989; Perry and Gordon, 1991; Dirnagl et al., 1999). Ischemic injury not only causes 
endogenous parenchymal cell damage, but also involves inflammatory responses that 
include the infiltration and accumulation of neutrophils and monocytes/macrophages due 
to breakdown of the blood-brain barrier (Barone et al., 1991). The activated microglia and 
infiltrating leukocytes serve as sources for H2O2 as well as MPO in ischemic brains. 
Reduced brain leukocyte MPO activity with hyperbaric oxygen treatment has 
neuroprotective effects on experimental focal ischemic brains (Miljkovic-Lolic et al., 
2003).  
1.3.1.4 MS 
MS is a chronic inflammatory demyelinating disease of the CNS with the 
pathological hallmarks of inflammation, demyelination, axon loss and gliosis. Studies 
have demonstrated that MPO genotypes are associated with the susceptibility for MS 
(Kantarci et al., 2000; Nelissen et al., 2000; Zakrzewska-Pniewska et al., 2004). In MS, 
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the expression of MPO was found present in microglia/macrophages in and around MS 
lesions (Nagra et al., 1997).  
 
1.3.2 Possible routes of HOCl generation in diseased brains 
Not only microglia, essentially all cells in brain participate for HOCl generation 
for example NADPH oxidase and MPO too present in neurons.    
1.3.2.1 Sources of H2O2 
Because H2O2 can derived from the dismutation of O2.-, sources of O2.- generation will 
also be considered as sources of H2O2. 
1.3.2.1.1 NADPH oxidase 
Rossi and Zatti (1964) first proposed that a NADPH oxidase was responsible for 
the respiratory burst of phagocytes, such as neutrophil and monocyte/macrophage. 
Although the initial product of the respiratory burst is O2.- but H2O2 can be formed 
subsequently by dismutation. A body of evidence suggests that the migration of 
phagocytes from the microvascular system, and their infiltration into parenchymal tissues, 
and across the blood-brain barrier, is a key event in brain tissue inflammation and injury 
(Kochanek and Hallenbeck, 1992; Akopov et al., 1996). Astrocytes and oligodendrocytes, 
the most abundant cell types in the brain, are activated to release chemokines that recruit 
peripheral phagocytes to the affected brain area (Johnstone et al., 1999). Several 
investigators have reported that activated neutrophils are involved in the development of 
cerebral damage induced by ischemia (Kochanek and Hallenbeck, 1992; Matsuo et al., 
1995). Macrophage and monocytic infiltration are also reported in MS (Deloire et al., 
2004), AD (Fiala et al., 2002) and HIV-1-associated dementia (Boven et al., 2000; 
Persidsky et al., 2000).  
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Aside from peripheral phagocytes, the most obvious cell to possess an NADPH 
oxidase in the CNS is the microglial cell. Microglia are resident cells of the CNS. 
However, as opposed to neurons, astrocytes, and oligodendrocytes, which are all derived 
from neuronal precursor cells, microglia are of myeloid origin. Thus, it can be viewed as a 
very specialized macrophage with its own replication cycle within the CNS. In accordance 
with its phagocyte origin, NADPH oxidase is expressed in microglia and it is activated 
upon stimulation of Aβ in vitro (Bianca et al., 1999). Shimohama and co-workers (2000) 
showed that NADPH oxidase is activated in AD brains by demonstrating the marked 
translocation of the cytosolic factors p47-phox and p67-phox to the membrane. Increasing 
evidence also suggests a role for glial activation in the pathogenesis of PD (Gonzalez-
Scarano and Baltuch, 1999; Liu and Hong, 2003). Microglial NADPH oxidase-derived 
ROS markedly enhanced rotenone-induced degeneration of dopaminergic neurons (Gao et 
al., 2003b) as well as in vitro MPTP model of PD (Gao et al., 2003a). In addition, 
monocytes that possess NADPH oxidase are found migrate across the blood-brain barrier 
when attracted by chemokines and be neuronotoxic or neuroprotective (Fiala et al, 2002) 
and differentiate into microglia in brain (Eglitis and Mezey, 1997).  
In addition to phagocytes, NADPH oxidase is also found in non-phagocytic cells. 
More recently, a relatively large number of studies have demonstrated that various 
subunits of NADPH oxidase are also expressed in sympathetic ganglion neurons and 
cortical neurons (Noh and Koh, 2000; Tammariello et al., 2000; Vallet et al., 2005) 
NADPH oxidase-mediated neuronal O2.- production and its conversion to H2O2 is 
responsible for Aβ-induced apoptosis in neurons (Behl et al., 1994; Jana and Pahan, 
2004). NADPH oxidase is also identified in cerebrovascular system (Park et al., 2005) 
and is a major source of vascular ROS (Griendling et al., 1994; Li and Shah, 2004). 
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Vascular NADPH oxidase found throughout the vascular wall (in endothelial cells, 
vascular smooth muscle cells and adventitial fibroblasts) (Griendling et al., 2000) appears 
to be constitutively active, producing a continuous low-level O2.- (Paravicini and Sobey, 
2003). In AD, deposits of Aβ-peptides are seen in the cerebral blood vessels (Davis et al., 
2004; Zlokovic et al., 2005). Aβ interact with endothelial cells on blood vessels to 
produce an excess of O2.- via endothelial NADPH oxidase (Stamler, 1996; Thomas et al., 
1996). Again, Park et al (2005) suggested that vascular NADPH oxidase is a key factor in 
the cerebrovascular dysfunction induced by Aβ.  
1.3.2.1.2 Other H2O2-generating enzymes 
 Within the brain, there still other H2O2-producing enzymes, including monoamine 
oxidase (MAO), cyclo-oxygenase (COX), and xanthine oxidase. MAO is one of the main 
enzymes which catabolize catecholamines and serotonin and produces H2O2 as a by-
product. MAO is widely distributed in the CNS, and is present in two main isoforms, 
MAO-A and MAO-B. In the brain, MAO-A presents mainly in catecholaminergic 
neurons, whereas MAO-B is primarily present in glia and in serotonergic neurons 
(Westlund et al., 1988; Saura et al., 1996). Previous enzymatic assays performed on 
postmortem human brain tissue suggest that MAO-B levels in glial cells (Halliwell, 1992; 
Ekblom et al., 1993) increase with age (Robinson et al., 1971; Fowler et al., 1980; 
Kornhuber et al., 1989; Sastre and Garcia-Sevilla, 1993; Galva et al., 1995) and in 
neurodegenerative disease (Adolfsson et al., 1980; Strolin Benedetti and Dostert, 1989). 
Several reports indicate that both forms of MAO are altered in AD (Reinikainen et al., 
1988; Nakamura et al., 1990; Saura et al., 1996; Emilsson et al., 2002). An increase in 
MAO activity in AD brain tissues is considered to contribute to the formation of even 
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higher levels of H2O2 (Saura et al., 1994). MAOB was increased (26%) in the frontal 
cortex from patients dying with HD compared to control subjects (Mann et al., 1986).  
COX that plays a pivotal role in the arachidonate cascade leading to prostaglandin 
synthesis are increased in AD brain and may correlate with levels of Aβ peptide (Pasinetti 
and Aisen, 1998; Kitamura et al., 1999).  Xanthine oxidase activity is increased after 
traumatic brain injury in rat (Solaroglu et al., 2005). Xanthine oxidase is also responsible 
for the generation of H2O2 in the cerebral circulation (Beetsch et al., 1998). H2O2 is also 
generated by SOD in the process of the inactivation of the O2.- and by auto-oxidation.  
 
1.3.2.2 Sources of MPO 
MPO is a tetrameric, heavily glycosylated, heam-containing enzyme of ~150 kDa. 
It is abundant in primary azurophilic granules of leukocytes including neutrophils 
(Hampton et al., 1998b), monocytes/macrophages (Daugherty et al., 1994) and microglia 
in brain (Nagra et al., 1997) and secreted into phagolysosomal compartment following 
phagocyte activation by a variety of agonists, for example Aβ (Hampton et al., 1998b). 
MPO also can be released to the outside of the cell by leakage before complete closure of 
the developing phagosome or in response to stimulation by an antibody/complement-
coated surface too large to be ingested (Klebanoff, 2005). Typically, phagocyte activation 
and MPO secretion are accompanied by an oxidative burst where H2O2 is formed by the 
NADPH oxidase complex. In the presence of H2O2 and Cl-, MPO kills many bacteria and 
fungi in vitro. MPO kills by oxidizing Cl- into highly reactive HOCl. Hence, MPO 
amplifies the oxidizing potential of H2O2 by using it as co-substrate to generate a host of 
reactive oxidants and diffusible radical species.  
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MPO can arise in the brain either from glial cells or infiltrating neutrophils as well 
as monocyte/macrophages. Neuronal expression of MPO is also demonstrated (Green et 
al., 2004). MPO is normally not present in the brain parenchyma but is found in AD 
(Reynolds et al., 1999), ischemia (Furuichi et al., 2004), PD (Choi et al., 2005) and MS 
(Nagra et al., 1997). The signals responsible for the induction of MPO expression in the 
brain have not been elucidated but Aβ and cytokines are two possibilities. The deposition 
of aggregated Aβ is postulated to be a major etiological factor in AD and these aggregates 
stimulate the production of MPO message in cultured rodent glial cells (Reynolds et al., 
1999). MPO is also expressed in the advanced human atheroma, in a manner that is 
regulated by granulocyte-macrophage colony-stimulating factor (Sugiyama et al., 2004) 
which is associated with the development of AD (Tarkowski et al., 2001). 
 
1.3.3 Destructive effects of HOCl generation  
1.3.3.1 Direct damage of biomolecules 
HOCl is highly reactive and powerful two-electron oxidizing agent possesses the 
ability to damage proteins, lipids, and DNA by oxidation or chlorination. It has many 
biological targets for oxidation where thiols and thioethers are particularly reactive 
whereas other compounds including ascorbate, urate, pyridine nucleotides, and tryptophan 
are not as rapidly (Albrich et al., 1981; Winterbourn, 1985). For chlorination, HOCl reacts 
with amine groups to give chloramines (Thomas et al., 1986; Prutz, 1996; Prutz, 1998); 
with cytosine residues in nucleic acids and tyrosyl residues in protein to give ring 
chlorinated products (Kettle, 1996; Henderson et al., 1999); with unsaturated lipids and 
cholesterol to give chlorohydrins (Winterbourn et al., 1992; Heinecke et al., 1994).   
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Proteins are the major targets for HOCl within complex biological systems 
(Hawkins et al., 2003). The reaction of proteins with HOCl can lead to side-chain or 
backbone amides modifications; for the latter being a slower process (Hawkins et al., 
2003). Side-chain modifications do not result in fragmentation or aggregation of proteins. 
Modifications of amino acid side-chain give rise to nitrogen-chlorine derivatives such as 
monochloramines and dichloramines, which can degrade to the corresponding aldehyde. 
The chloramines are long-lived, thus providing a mechanism for the prolongation of the 
oxidant activity of the peroxidase system and for the penetration of HOCl into complex 
biological fluids to be toxic at a distance under conditions in which the more reactive 
products are readily scavenged. Some of these are well characterized (e.g. 3-
chlorotyrosine), while the identities of other products are ambiguous or have not been 
studied in any detail. On the other hand, reaction of HOCl with the backbone amide 
groups of proteins results in the formation of chloramides (Prutz, 1999) leading to protein 
fragmentation via direct cleavage of the peptide bonds (Hawkins and Davies, 1998) or 
protein aggregation (Hawkins et al., 2003). Consequently, the reaction of HOCl with 
proteins can have severe effect if the modification is at or near the enzyme active site, 
which can lead to inhibition of enzymatic activity. In addition, HOCl-damage proteins can 
induce changes to other biological targets. For example, free chloramines derived from 
amino acid are toxic towards cells.  
In lipids the major sites of attack by HOCl are the double bonds of unsaturated 
fatty acids and cholesterol leading to chlorohydrin formation. Chlorohydrin if formed in 
cell membranes could destabilize membrane structure, since they are more polar than the 
parent fatty acids and chlorohydrin also itself cytotoxicity (Vissers et al., 2001a). 
However, the rate of chlorohydrin formation is relatively slow and so these materials are 
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relatively minor products in most situations (Carr et al., 1996; Carr et al., 1997; Vissers et 
al., 2001a; Pattison et al., 2003). Whereas, reaction with the base moiety of nucleotide is 
known to result in the formation of short-lived chloramine species which can lead to the 
dissociation of double stranded DNA due to the disruption of hydrogen-bonding (Prutz, 
1998).  
Up to date, there is no known enzymatic scavenging mechanism for HOCl. The 
main scavenger of HOCl in bodily fluids appears to be the thiol-based antioxidants: GSH 
and taurine (Wasil et al., 1987; Aruoma et al., 1988). Antioxidants, such as ascorbate, 
some phenols and hydroquinones, can also react rapidly with HOCl (Halliwell et al., 
1987; Kato et al., 2003; Pattison et al., 2003). In most biological systems, however, 
reaction with these antioxidants with the exception of reaction with GSH and possibly 
ascorbate, is likely to be uncompetitive with reaction with amino acids, peptides and 
proteins as a result of their abundance and their high reactivity with HOCl (Pattison and 
Davies, 2001).  
1.3.3.2 Destruction of extracellular matrix (ECM) 
ECM is a complex structure consisting of proteins and proteoglycans (PGs) that 
acts as a scaffold for cells and at the same time regulates their growth. Proteolysis of ECM 
proteins is a key event in many destructive inflammatory conditions and is normally 
carried out by matrix metalloproteinases (MMPs) (Woessner and Nagase, 2000). MMPs 
are regulated at the level of both gene transcription and activation of proenzymes (Nelson 
and Melendez, 2004). Phosphorylation of AP-1 as a consequence of MAPK activation 
facilitates its translocation into the nucleus and augmentation of MMPs transcription. 
HOCl has been identified as a signaling molecule activating the MAPKs (Midwinter et 
al., 2001). HOCl can also cause destruction of ECM by activating MMPs, by inhibiting 
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the inhibitor of MMPs or by direct degradation of the protein core (hyaluronic acid) and 
the sulphated glycosaminoglycans of PGs (Hawkins and Davies, 1998).  
1.3.3.3 Cell death 
Cell death induced by HOCl is so far understudied. Most of the researches were 
done on non-neuronal cells for instance human liver cells (Whiteman et al., 2005), 
epithelial cells (Cantin, 1994), endothelial cells (Vissers et al., 1999, 2001b; Sugiyama et 
al., 2004), neutrophils (Carr and Winterbourn, 1997), erythrocyte (Zavodnik et al., 2000), 
and transformed leukocytes (Englert and Shacter, 2002; Wagner et al., 2002). HOCl 
induces rapid cell lysis in blood cells, while all other cell types displayed a continuum of 
apoptosis and necrosis. The work of Krasowska and Konat (2004) represent the only piece 
of HOCl study in brain where HOCl represses ATP-dependent processes without causing 
any morphological change in brain slice.  
In apoptosis caused by HOCl, caspase activation (Vissers et al., 1999; Sugiyama et 
al., 2004; Whiteman et al., 2005) and mitochondrial permeability transition with 
concomitant release of cytochrome c (Whiteman et al., 2005) were documented. HOCl 
also induces immediate depletion of intracellular ATP and GSH levels (Vissers and 
Winterbourn, 1995; Carr and Winterbourn, 1997; Whiteman et al., 2002; Jenner et al., 
2002; Whiteman et al., 2003).  In turn, GSH-depletion by HOCl might play a key role in 
the degradation of anti-apoptotic Bcl-2 protein (Sugiyama et al., 2004). Moreover, 
toxicity of HOCl can also due to its modification of cell-surface proteins (Pullar et al., 
2000). Vissers et al. (1999) demonstrated that HOCl caused growth arrest in human 
endothelial cells. Besides, HOCl also mediates increase of intracellular calcium 
concentration by inhibiting Ca2+-ATPase as well as activating of Ca2+ release channel 
(Fukui et al., 1994; Favero et al., 1998; Favero et al., 2003).  
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1.4 RATIONALE AND OBJECTIVE OF THE STUDY 
 
1.4.1 Rationale 
Excessive neuronal loss in the affected brain regions is a common phenomenon 
among neurodegenerative disorders. However, there is no effective treatment currently 
available for the diseases. Thereby, more studies and discoveries of death pathways are 
required to open new perspectives for the treatment.  
Oxidative stress is found involved in at least the propagation of cellular injury 
during pathological conditions. There is a compeling of evidences showing the association 
of HOCl, a major oxidant generated by phagocytes, to neurodegeneration: (i) HOCl 
contributes to both oxidative and nitrative processes unifying in disease progression; (ii) 
there are rich sources of HOCl formation in diseased brains; (iii) HOCl scavenging ability 
of neuroprotectant, desferrioxamine and uric acid and (iv) elevation of HOCl biomarker, 
3-chlorotyrosine, in disease affected brain regions. In view of the above evidences, the 
highly reactive HOCl is likely to be the primary oxidant responsible for bystander CNS 
tissue damage during neurodegenerative disorders. Regarding its role in 
neurodegenerative diseases, HOCl is still an under appreciated oxidant.  
 
1.4.2 Objective 
Accordingly, the objective of this study is to inspect the mechanisms of HOCl-
mediated neuronal apoptosis. We explored the potential role of common apoptotic 
elements, caspase, calpain as well as cathepsin as they are relevant in neurodegenerative 
diseases. Moreover, apoptosis often links to the activation of the genome and resultant de 
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novo protein synthesis. Therefore, microarray analysis was carried out to identify HOCl-

































CHAPTER 2  














2.1 PRIMARY CULTURE OF MOUSE CORTICAL NEURONS 
2.1.1 Plate coating  
 Culture plates (Nalge Nunc International, Rochester, NY), coverslips and 4-well 
chambered coverglass were coated with poly-D-lysine (Sigma) on the day before cell 
culture. For coating of culture plates and coverslips, 5 mg of poly-D-lysine was dissolved 
in 50 ml water while 40 mg/50 ml poly-D-lysine was needed for coverglass. The poly-D-
lysine solution was filtered through a 0.2 μm filter. For each well in a 24-well plate, 300 
μl poly-D-lysine was added and incubated overnight at 37˚C in an incubator (Binder 
Corporation). After incubation, the plates were washed once with 1 ml water per well and 
left dry for subsequent use or refilled with same amount of water and store at 4˚C.  
2.1.2 Cell culture 
Cortical neurons were obtained from embryonic day 15 or 16 Swiss-white mice as 
described (Cheung et al., 1998, 2000). In brief, cortex was dissected from brain under 
sterile condition and suspended in ice-cold Hank’s Balanced Salt Solution (HBSS). The 
mixture was spun at 1000 × g for 1 min at 15˚C with supernatant discarded. The pellet 
was dislodged in HBSS containing trypsin and DNase for 5 min at 37ºC with shaking. 
After incubation, trypsin inhibitor was added to terminate trypsin digestion and the cells 
were mechanically dissociated by trituration (15 strokes with a 24-gauge needle). Clear 
lysate after trituration was collected and the cells were spun down (5 min, 1000 × g, 15˚C) 
and resuspended in Neurobasal™ (NB) medium (Gibco™, Carlsbad, CA) containing 1% 
penicillin-streptomycin (Sigma) and 10% dialyzed fetal calf serum (Sigma), 2.5% B27 
(Gibco™), 0.25% GlutaMAX™-I (Gibco™). Cells were seeded in 24-well plates coated 
with poly-D-lysine to a density of 0.5 × 106 cells/well. After 24 h in vitro, the culture 
medium was replaced with 0.5 ml/well phenol red-free DMEM/F-12 medium (Sigma) 
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containing 2.5% B-27, 0.25% GlutaMAX™-I. The cultures were maintained in a 
humidified CO2 incubator (5% CO2, 37ºC).  
 
2.2 MEASUREMENT OF HOCl 
HOCl stock (Sigma) was diluted 200 times in pH 12.0 buffer (100 mM K2HPO4-
KOH) and was quantified spectrophotometrically at 290nm (pH 12.0, ε = 350 M-1.cm-1) 
every time before use (Morris, 1966). The stock concentration was calculated using Beer-
Lambert Law [C = (A290/ε) × dilution factor]. Afterward, stock HOCl was diluted in water 
to a concentration of 300 mM and stored on ice for no longer than 1 min (Vissers et al., 
1999, 2001b; Midwinter et al., 2001; Jenner et al., 2002; Whiteman et al., 2003, 2005). 
300 mM HOCl was further diluted with EBSS without phenol red (Sigma) warmed to 
37˚C to desired concentration.  
 
2.3 INDUCTION OF APOPTOSIS 
Neurons were treated with 0.5 ml/well of HOCl in EBSS on day 5 in vitro (DIV5) 
cultures either alone or pre-incubated with inhibitors [10 μM calpeptin (Calbiochem, 
Darmstadt, Germany), 10 μM SJA6017 (Calbiochem), 5 μM Z-FF-FMK (Calbiochem), 5 
μM pepstatin A (Sigma), 5 μM Z-FL-COCHO (Calbiochem), 10 μM CA-074 Me 
(Calbiochem)], Ca2+ chelator [1 mM EGTA (Merck, Darmstadt, Germany)] or Ca2+ 
channel antagonists [40 μM flufenamic acid (Sigma), 10 μM dantrolene (Sigma), 10 μM 
nifedipine (Sigma)]. The addition of HOCl did not significantly alter the pH of the 
reaction mixture. After 3 h, EBSS was removed and followed by the addition of 0.3 
ml/well of DMEM/F-12 medium with phenol red (Sigma) to wash off HOCl. However, 
cells were directly treated with 0.3 ml/well 0.5 μM staurosporine (STS; Sigma) or 0.1 μM 
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colchicine (Sigma) in DMEM/F-12 for 24 h as positive control in the following 
experiments.  
 
2.4 ASSESSMENT OF CELLULAR VIABILITY 
MTT [3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide] was 
dissolved in RPMI medium 1640 (Invitrogen, Carlsbad, CA) at a stock concentration of 5 
mg/ml (Cheung et al., 2004a).  MTT solution (30 μl) was added to each well of the 24-
well plate containing cells in 300 μl culture medium and the plate was incubated at 37°C 
for 30 min.  The culture medium was then removed by aspiration and the plates were air 
dry. An aliquot of 200 μl DMSO (Merck) was added to dissolve the formazan formed in 
each well and the absorbance of the solution was read at 570 nm. Results were expressed 
as percent MTT reduction. Leakage of lactate dehydrogenase (LDH) into the culture 
media was measured at 490nm using a CytoTox 96 kit (Promega, Madison, WI). Briefly, 
20 min prior to medium harvest, 0.1% Triton X (Merck) was added to cells and incubated 
at 37˚C as maximum LDH release control. Then, 50 μl medium from each well was 
transferred to a 96-well plate. 50 μl reconstituted Substrate Mix containing lactate and 
NAD+ was added to each well and incubated for 30 min at room temperature in the dark. 
The reaction was stopped by adding 50 μl of 1 M acetic acid. Absorbance was read at 490 
nm and result expressed as a % LDH activity from cells lysed with 0.1% Triton X. All the 




2.5 MORPHOLOGICAL ASSESSMENT OF CELL DEATH 
Cell death was assessed using Hoechst nuclear staining as described previously 
(Cheung et al., 2004b). Without removal of the medium, cells treated with HOCl were 
incubated live with 100 μl Hoechst 33342 (Sigma, 20 μg/ml in medium from a 2 mg/ml 
stock in water) for 15 min at 37˚C. Annexin V binding was performed according to 
protocol provided along with Annexin V-FITC Apoptosis Detection Kit (Sigma) with 
modification (Cheung et al., 2004b). The culture medium was removed and cells were 
stained live with 2 μl of Annexin V-FITC conjugated plus 0.5 μl of propidium iodine in 
300 μl of binding buffer. Cells were then incubated at 37˚C for 15 min. After staining with 
Hoechst or Annexin V, cells were visualized immediately using fluorescence microscopy 
(Leica; model DMIRB) with appropriate filter.  
 
2.6 TRANSMISSION ELECTRON MICROSCOPY (TEM) 
Cortical neurons were cultured in 4-well chambered coverglass, treated with HOCl 
or STS for 24 h, and fixed with 3% glutaraldehyde and 2% paraformaldehyde in 0.1 M 
cacodylate buffer for 45 minutes at room temperature. After osmication in 2% osmium 
tetroxide, specimens were dehydrated in an ascending series of ethanol and embedded in 
araldite. Ultrathin sections were cut, mounted on formvar-coated copper grids, and 
doubly-stained with uranyl acetate and lead citrate before viewing in a Phillips BioTwin 
CM120 transmission electron microscope (Phillips Electron Optics, Eindhoven, The 





2.7 WESTERN BLOTTING 
2.7.1 Protein extraction  
Proteins were extracted and pooled from 6 wells with 200 μl RIPA buffer (10 mM 
Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 2mM EGTA, 1% Nonidet-P 40, 0.5% 
sodium deoxycholate, 25 mM sodium fluoride, 2 mM sodium orathovanadate, 10 mM 
sodium pyrophosphate, and 0.1% SDS) containing protease inhibitor cocktail tablet 
(Roche Diagnostics GmbH, Mannheim, Germany) and cell lysate was incubated overnight 
at -20˚C. Next day, the lysate was thawed on ice and centrifuge at maximum speed for 10 
min at 4˚C with supernatant collected and store at -20˚C for succeeding use.  
2.7.2 Protein determination 
Protein concentrations were determined by the Lowry method (RC DC kit, Bio-
Rad Laboratories, Hercules, CA). Protein standards ranged from 0.2 mg/ml to 1.5 mg/ml 
bovine serum albumin (BSA) (Sigma) in lysis buffer were prepared.  25 μl of standards 
and samples were pipetted into clean dry microfuge tubes and performed duplicate. 125 μl 
RC Reagent I was added into each tube and incubated for 1 min at room temperature. 
Next, 125 μl RC Reagent II was added into each tube and centrifuge at 15,000 × g for 5 
min with supernatant discarded. The liquid was drained completely from the tubes. The 
precipitate in each tube was dissolved completely with 127 μl Reagent A’ (5 μl DC 
Reagent S + 250 μl DC Reagent A). The mixture was vortexed and followed by the 
addition of 1 ml DC Reagent B and incubated at room temperature for 15 min. The 
solutions were transferred to a 1 ml cuvette and absorbances read at 750 nm using 




2.7.3 Sample preparation for protein electrophoresis 
After protein measurement, 15 μg proteins were used for protein electrophoresis. 
Prior to electrophoresis, protein samples were mixed with loading buffer (0.5 M Tris-HCl, 
pH 6.8, 20% (v/v) glycerol, 10% sodium dodecyl sulphate (SDS), 0.01% bromophenol 
blue and 20% β-mercaptoethanol) in a 4:1 ratio and heated at 100˚C for 5 min to denature 
the proteins. After heating, the samples were centrifuged at maximum speed for 2 min to 
remove the insoluble.  
2.7.4 SDS-polyacrylamide gel preparation 
 A discontinuous system (a non-restrictive large pore gel, called a stacking gel, is 
layered on top of a separating gel called a resolving gel) was used. Volumes given for gel 
preparation (10 ml of monomer) were sufficient for two small (8 cm × 10 cm × 1.0 mm) 
gels. Scale up volumes as needed. 10% ammonium persulfate (APS) (Bio-Rad 
Laboratories) (0.1 g APS in 1 ml of water) was prepared prior to use. 
2.7.4.1 Pouring resolving gel 
Set up the gel apparatus, resolving gel monomer was prepared with 10% APS and 
TEMED (Fluka, Buchs SG, Switzerland) included just prior to pouring gel.  
Component 6% 12% 
Water 5.4 ml 3.4 ml 
30% Acrylamide/Bis (Bio-Rad) 2 ml 4 ml 
6 M Tris-HCl, pH 8.8 2.5 ml 2.5 ml 
10% SDS (NUMI) 0.1 ml 0.1 ml 
10% APS 50 μl 50 μl 
TEMED 5 μl 5 μl 
 
The gel monomer was allowed to polymerize before adding stacking gel by overlaying 
gently with water. 6% resolving gel was used only for the study of α-fodrin.  
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2.7.4.2 Pouring stacking gel 
Stacking monomer was mixed as designated below. Likewise, 10% APS and TEMED 
were added just prior to pouring.  
Component 4% 
Water 6.1 ml 
30% Acrylamide/Bis 1.3 ml 
2 M Tris-HCl, pH 6.8 2.5 ml 
10% SDS 0.1 ml 
10% APS 50 μl 
TEMED 10 μl 
 
After the separating gel has polymerized, the overlay was decanted and the stacking 
monomer was poured. The comb was inserted and monomer was left to polymerize 
completely before running. 4% stacking gel was used.   
2.7.5 Protein electrophoresis 
Proteins were separated in polyacrylamide gels immersed in electrophoresis buffer 
(192 mM glycine, 25 mM Tris, and 0.1% SDS) and ran at 40 V till the loading dye 
migrated into resolving gel. After that, voltage was changed to 120 V. 3 μl Protein marker 
(Bio-Rad Laboratories) was ran together with the samples.  
2.7.6 Blotting -- Transfer proteins from gel to PVDF 
After the gel has finished running, the glass plates and the stacking gel were 
carefully removed. The gel was washed and equilibrated using transfer buffer (25 mM 
Tris, 192 mM glycine, and 20% methanol) for 5 min with shaking at room temperature. 
Prior to use, filter papers (Whatman, Middlesex, UK) and cassette sponges (Bio-Rad 
Laboratories) were hydrated using transfer buffer while PVDF was socked in absolute 
methanol. PVDF pre-wetted with absolute methanol was carefully lay across the protein 
gel with no air bubble formed between the gel and membrane. Two layers of pre-wetted 
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filter paper were stacked onto the membrane and gel. In the same fashion, pre-wetted 
cassette sponges were added to the stack. The ‘sandwich’ was put into a cassette and 
snapped together firmly then placed into the transfer unit. As such, gel would be closer to 
the black (-) cathode whereas the membrane closer to the red (+) anode. Transfer unit was 
filled with chilled transfer buffer and run at 100 V for 1 h.  
2.7.7 Blocking  
Before blocking, the blot was equilibrated using TBS (50 mM Tris, 150 mM NaCl, 
pH 7.5) for 5 min at room temperature with shaking. Later, the blot was blocked with 20 
ml 5% skimmed milk (Anlene, Auckland, New Zealand) in TBS containing 0.1% Tween-
20 (TBST) for 1 h at room temperature with gently shaking. The blot was rinsed with 2 × 
5 min TBST. 
2.7.8 Probing the blot 
After blocking, the membrane was probed with appropriate primary antibodies 
diluted in TBST containing 5% BSA and incubated overnight at 4˚C. The primary 
antibodies used were as follows: active-caspase 3 antibody (1:1000; BD Biosciences 
PharMingen, San Diego, CA), α-fodrin antibody (1:500; Chemicon International, Inc., 
Temecula, CA), heat shock protein 70 (1:100; Oncogene Research Products, San Diego, 
CA), cyclin D1 and cyclin D3 (1:1000; Cell Signaling Technology, Beverly, MA), 
activating transcription factor-3 (ATF-3) (1:1000; Santa Cruz Inc, Santa Cruz, CA) and β-
tubulin antibody (1:1000; Cytoskeleton, St. Denver, CO). The primary antibody was 
removed and the blot was washed 3 × 5 min in TBST at room temperature with shaking. 
Afterward, the blot was incubated with diluted secondary antibody (horseradish 
peroxidase-conjugated anti-rabbit IgG, 1:10,000 or anti-mouse IgG, 1:5000) in blocking 
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solution for 1 h at room temperature with shaking. After incubation with secondary 
antibody, the blot was again washed 3 × 5 min in TBST.  
2.7.9 Detection  
SuperSignal West Femto Chemiluminescent Substrate (Pierce Biotechnology Inc., 
Rockford, IL, USA) was used for detection. Oxidizing and luminol reagent were mixed in 
a 1:1 ratio to a final volume of 600 μl for each blot. The substrate solution was pipetted 
onto the blot and left for 1 min. Then, protein bands were captured using Chemi-genius2 
Bio-imaging System operated with GeneSnap version 6.05.01 (Syngene Ltd, Cambridge, 
UK).  
2.7.10 Stripping and reprobing blot 
 To reuse the blot, Re-Blot Plus Western Blot Strong Antibody Stripping Solution 
(Chemicon) was used to remove previously probed antibodies. The blot was submerged in 
10 ml 1 × stripping solution and incubated with gentle mixing for 15 min at room 
temperature. Later, the blot was rinsed with 2 × 5 min TBST and blocked for 30 min and 
rinsed again with TBST. Follow section 2.7.8 to reprobe.  
 
2.8 CASPASE ACTIVITY MEASUREMENT 
Caspase activity was measured using caspase-family fluorometric substrate as 
instructed (BioVision, Mountain view, CA). Briefly, cells from 6 wells were harvested 
and lysed using 50 μl chilled Cell Lysis Buffer and were incubated on ice for 10 min. 
Later the supernatants were collected after centrifugation (30 min, 16000 × g, 4˚C). A 50 
μl reaction mixture consisted of 2 μl 25 × reaction buffer (250 mM HEPES, pH 7.4, 50 
mM EDTA, 2.5% CHAPS, 125 mM DTT), 36.5 μl water, 1.5 μl AFC conjugated 
substrates, and 10 μl supernatant was read in a fluorometer (Gemini XS 
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spectrofluorometer, Molecular Devices) equipped with a 400-nm excitation filter and 505-
nm emission filter. The protein concentrations were determined by the Lowry method as 
described in section 2.7.2. The relative fluorescence unit per microgram of protein 
(RFU/μg protein) in each sample was then calculated. 
 
2.9 FLUOROCHROME-LABELED INHIBITORS OF CASPASES (FLICA) 
STAINING 
Red fluorescing sulforhodamine (SR)-VAD-fmk (Immunochemistry 
Technologies, Bloomington, MN) was used. The inhibitor was dissolved in DMSO as 
specified in the kit to obtain 150 × concentrated (stock) solution. Prior to use a 30 × 
working solution of FLICA was prepared by diluting the stock solution 1:5 in PBS and 
mixing until become transparent and homogenous. After induction of apoptosis, living 
cells were incubated together with 10 μl of FLICA working solution in 300 μl culture 
medium for 1 h at 37˚C. Later, the cells were rinsed twice with washing buffer provided 
(0.5 ml/well). The cells were protected from light throughout the procedure. Stained cells 
were viewed under fluorescence microscopy (Leica). Cells with active caspases fluoresce 
red, while cells without active caspases will appear mostly unstained.  
 
2.10 INTRACELLULAR CA2+ MEASUREMENT 
Cells seeded onto poly-D-lysine coated cover slips were loaded with 3 μM fura-
2/acetoxymethyl ester (Molecular ProbesTM, Carlsbad, CA) for 40 min at room 
temperature in phenol red-free DMEM/F-12, followed by washing with EBSS and further 
incubation for 30 min at room temperature for de-esterification. Fluorescence 
measurements were performed at room temperature on small groups of dispersed cells 
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viewed with an upright microscope (Nikon E600FN, Japan) using a Fluor 40× (0.80W) 
water-immersion objective as previously described (Yang et al., 2004). Fura-2 
fluorescence was excited alternatively at 340 and 380 nm through a LAMDA 10-2 filter 
wheel (Sutter, USA) with 100 W mercury illumination. Emitted fluorescence was filtered 
with EX 340/380 nm DM400 BA510 filters (Chroma Technology, USA) and measured 
with a SensiCam cooled CCD camera (PCO, Axon Instruments, USA). Video images 
were digitized onto a computer and analyzed using Axon Imaging Workbench AIW 
software. For each cell, [Ca2+]i was averaged from pixels within manually outlined cell 
areas. 10 μl of HOCl (final concentration 250 μM) was externally added to EBSS with 
minimum cellular disturbance. 
 Calibrations were performed using the Fura-2 Calcium Imaging Calibration Kit 
(Molecular Probes) to obtain values for Rmin, Fmax380, Fmin380, Rmax, and Kd. The [Ca2+]i 
was calculated as previously described (Grynkiewicz et al., 1985). Briefly, using formulas 
as shown below, ratio values were converted to Ca2+ concentrations. [Ca2+]free=Kd× 
(R−Rmin)/(Rmax−R) ×[Fmax380/Fmin380] where R is the ratio of emission intensity exciting at 
340 nm to that exciting at 380 nm; Rmin is the ratio at zero free Ca2+; Rmax is the ratio at 
saturating Ca2+ (e.g. 39 μM); Fmax380 is the fluorescence intensity exciting at 380 nm, for 
zero Ca2+; and Fmin380 is the fluorescence intensity at saturating free Ca2+. The free Ca2+ 
for any experimental sample can then be calculated from the corresponding R value. The 
plot of the log of [Ca2+]free (x-axis) versus the log of (R−Rmin)/(Rmax−R) ×[Fmax380/Fmin380] 
yields a straight line, the X-intercept of which is the log of Kd. Thus, an empirical value 
for Kd can be determined from the fura-2-containing Ca2+ standards. The [Ca2+]i was 
calculated after background subtraction. The background can be determined by the blank 
buffer without fura-2 that is provided in the calibration kit. 
 44
2.11 ASSESSMENT OF LYSOSOMAL MEMBRANE INTEGRITY 
The integrity of the lysosomal membrane and the maintenance of a lysosomal-
cytosolic pH gradient were assessed using the acridine orange (AO) relocation technique 
(Zdolsek et al., 1990). In this approach, cells are incubated with a fluorogenic organic 
weak base which diffuses into cells and accumulates in lysosomes and related acidic 
vacuoles by proton-trapping (Olsson et al., 1989). This accumulation produces a change 
in the fluorescence emission of the probe (from green to red for acridine orange, due to 
concentration-dependent stacking of the molecules). Disruption of the lysosomal 
membrane and/or marked change in lysosome pH can, therefore, be assessed by 
measuring the change in emission ratio in comparison to controls and by visual inspection 
of the cells by fluorescence microscopy (Choi et al., 2002). Living cells in each well were 
stained with 300 μl 5 μg/ml AO (Sigma) in PBS for 15 min at 37˚C. Cells were washed 
twice in PBS (0.5 ml/well). The relative intensities of red and green fluorescence were 
simultaneously examined microscopically using blue light for excitation. On being excited 
by blue light, protonated AO in lysosomes emits granular red fluorescence, whereas 
unprotonated AO in cytosol emits a diffuse green fluorescence. As a result, the decrease 
of granular red fluorescence in combination with the increased diffuse green fluorescence 
may imply the deterioration of lysosomal proton gradient and thereby membrane integrity. 
The fluorescence was viewed under microscopy (Leica) and image was captured by 






2.12 MICROARRAY ANALYSES 
2.12.1 Target preparation 
2.12.1.1 Total RNA extraction  
Total RNA from a 24-well plate was extracted wholly with RNeasy kit (Qiagen, 
Valencia, CA). Cells were lysed and harvested by the addition of buffer RLT (87.5 
μl/well) containing 1% β-mercaptoethanol. Buffer RLT is a strong denaturing buffer 
containing protein denaturant (guanidine isothiocyanate), which inactivates RNases. The 
lysate from 4 wells were pooled together into a 1.5 ml tube then homogenized by passing 
10 times through a 21½ gauge needle fitted to an RNase-free syringe. One volume of 70% 
ethanol was then added to the homogenized lysate so as to obtain appropriate binding 
conditions. All homogenized samples from the same plate were applied to an RNeasy 
mini column which contains a silica-gel-based membrane to adsorb total RNA. After 
binding, washing steps were implied to get rid of contaminants such as salts, proteins and 
other cellular impurities. First, 700 μl buffer RW1 was applied to the column and 
centrifuged at maximum speed for 15 sec with flow-through discarded. Next, the column 
was further washed with 500 μl buffer RPE and spun as previous. The column was 
transferred to a new 1.5 ml tube and total RNA was then eluted with 30 μl of 
diethylpyrocarbonate (DEPC)-treated water. DEPC-treated water was prepared by 
dissolving DEPC (Sigma) in distilled water to a final concentration of 0.1%. The solution 
was then left to stand overnight at room temperature and autoclaved the next day for 30 
min. Aliquots of 2 μl and 5 μl of total RNA were used for spectrophotometric 




2.12.1.2 Quantity, purity and integrity determination of extracted total RNA  
Total RNA was diluted 50 times (2 μl total RNA plus 98 μl of DEPC-treated 
water) prior to quantification. The amount of RNA was quantified spectrophotometrically 
at 260nm (Beckman DU-64). Solution with one absorbance unit at 260nm contains 40 
μg/ml RNA. The purity of RNA was examined by its A260/A280 ratios. Pure RNA is 
expected to have an A260/A280 ratio of 2 (Sambrook et al., 1989).  
The integrity of total RNA extracted was checked using electrophoresis on a 
denaturing 1 % agarose gel (1.0 g of agarose in 100 ml MOPS buffer containing 1.1 % 
formaldehyde) and run using MOPS buffer (200 mM MOPS, 50 mM sodium acetate, and 
20 mM EDTA). RNA samples were loaded together with RNA sample loading buffer 
without ethidium bromide (Sigma) in a ratio of 2:1. The samples were heated to 65˚C for 
10 min before loading and then chilled on ice. The samples were run in at 100 V and then 
at a constant voltage of 5 V/cm across the two electrodes until the loading dye migrated to 
approximately two-thirds of the gel. To visualize the RNA bands, the gel was soaked in a 
0.5 μg/ml ethidium bromide (Bio-Rad Laboratories) solution for 15 min with gentle 
shaking, followed by two rinses with DEPC-treated water for 15 min. The gel was then 
viewed using ChemiGenius2 Bio Imaging System. The 28S ribosomal RNA bands should 
have approximately twice the intensity of the 18S RNA bands. 
2.12.1.3 One-cycle cDNA synthesis and its clean-up 
7 μg of extracted total RNA was used for cDNA synthesis. Prior to cDNA 
synthesis, Poly-A Controls were prepared and included in order to monitor the entire 
eukaryotic target labeling process. GeneChip Eukaryotic Poly-A RNA Control Kit was 
used for this step. The concentrated Poly-A Control Stock was diluted with the Poly-A 
Control Dil Buffer for 7 μg total RNA as summarized below.  
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Starting Amount Serial Dilutions Spike-in Volume 
Total RNA First Second Third  
7 μg 1 : 20 1 : 50 1 : 7.14 2 μl 
 
For first dilution, 2 μl of the Poly-A Control Stock was diluted with 38 μl of Poly-A 
Control Dil Buffer. Then, mixed thoroughly and spun down. Later, 2 μl of previously 
diluted Poly-A Control was again diluted with 98 μl Poly-A Control Dil Buffer and mix. 
Lastly, 4 μl of Poly-A Control from second dilution was mixed with 24.56 μl Poly-A 
Control Dil Buffer. At the end, 2 μl of Poly-A Control from third dilution was added to 7 
μg total RNA for subsequent cDNA synthesis.  
Double-stranded cDNA was synthesized with spike-in poly-A RNA control using 
Superscript II reverse transcriptase and a T7-Oligo(dT) primer. A mixture containing 
RNA sample, diluted poly-A RNA controls, and T7-Oligo(dT) Primer were prepared as 
listed. 
Components Volume (μl) 
Sample RNA Variable 
Diluted poly-A RNA controls 2 
50 μM T7-Oligo(dT) primer 2 
RNase-free water Variable 
Total 12 
 
The mixture was then incubated at 70˚C using a thermocycler (PTC-100TM Peltier 
Thermal Cycler, MJ Research) for 10 min, then placed on ice for at least 2 min for primer 
hybridization. In another tube, First-Strand Master Mix was prepared as listed below.  
Components Volume (μl) 
5 × 1st Strand Reaction Mix (250 mM Tris-HCl, 
pH8.3, 375 mM KCl and 15 mM MgCl2) 
4 
0.1 M DTT 2 




7 μl of First-Strand Master Mix was transferred to RNA/T7-Oligo(dT) Primer mix for a 
final volume of 19 μl. The mixture was mixed thoroughly and incubated at 42˚C for 2 
min. To start the first strand synthesis, 1 μl Superscript II reverse transcriptase was added 
and incubated at 42˚C for 1 h; then cool the sample for at least 2 min at 4˚C.  
Second-strand of cDNA was synthesized using One-Cycle cDNA Synthesis Kit. 
Before start, Second-Strand Master Mix was assembled as in the table below.  
Components Volume (μl) 
RNase-free Water 91 
5 × 2nd Strand Reaction Mix 30 
dNTP, 10 mM  3 
E. coli DNA ligase 1 
E. coli DNA polymerase I 4 
RNase H 1 
Total 130 
 
130 μl of Second-Strand Master Mix was added to first-strand synthesis sample for a total 
volume of 150 μl and incubated at 16˚C for 2 h. After incubation, 2 μl of T4 DNA 
polymerase was added and further incubated for 5 min at the same temperature. After 
incubation with polymerase, 10 μl of 0.5 M EDTA was added and preceded to cleanup of 
double-stranded cDNA.  
Sample Cleanup Module was used for cleaning up the double-stranded cDNA. 
cDNA Binding Buffer (600 μl) was added to double-stranded cDNA and the resulting 
mixture was then transferred to a cDNA Cleanup Spin Column sitting in a 2 ml collection 
tube and centrifuged for 1 min at 16,000 × g with the flow-through discarded. The spin 
column was then transferred to a new 2 ml collection tube and 750 μl cDNA wash buffer, 
was used to rinse the column. The cap of the spin column was opened and centrifuged at 
16,000 × g for 5 min to enable the membrane in the column to dry completely. Next the 
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spin column was transferred to a new 1.5 ml tube and cDNA was eluted with 14 μl of 
cDNA elution buffer, pipetted directly onto the membrane. 
2.12.1.4 Synthesis and clean-up of biotin-labeled cRNA  
Biotin-labeled cRNA was synthesized via in vitro transcription (IVT) using 
previously produced cDNA and GeneChip IVT Labeling Kit. For IVT, the reaction 
components were added in the order indicated below and incubated at 37˚C for 16 h. 
Components Volume (μl) 
cDNA (from section 13.3.4) 12 
RNase-free Water 8 
10 × IVT Labeling Buffer 4 
IVT Labeling NTP Mix 12 
IVT Labeling Enzyme Mix 4 
Total 40 
 
Sample Cleanup Module was used to remove unincorporated NTPs, so that the 
concentration and purity of cRNA can be accurately determined by 260 nm absorbance 
subsequently. The biotin-labeled cRNA was mixed with 60 μl of RNase-free water, 350 μl 
of IVT cRNA binding buffer, and 250 μl of absolute ethanol. Later, the mixture (700 μl) 
was applied to the IVT cRNA clean-up spin column in a 2 ml collection tube, centrifuged 
for 15 s at 16,000 × g with flow-through discarded. cRNA was washed with 500 μl IVT 
cRNA wash buffer and centrifuged at same speed for 15s. cRNA was washed again using 
500 μl of 80% ethanol and centrifuged as previous with the cap left opened in order to dry 
the membrane. The spin column was transferred and cRNA was then eluted with 11 μl of 





2.12.1.5 Quantification of cRNA 
The eluted cRNA was diluted 100 times prior to determine spectrophotometically 
at 260 nm as described in section 2.12.1.2. For quantification of cRNA when using total 
RNA as starting material, an adjusted cRNA yield must be calculated to reflect carryover 
of unlabeled total RNA. Using an estimate of 100% carryover, the formula below was 
used to determine adjusted cRNA yield: 
adjusted cRNA yield = RNAm - (total RNAi) (y) 
RNAm = amount of cRNA measured after IVT (μg) 
total RNAi = starting amount of total RNA (μg) 
y = fraction of cDNA reaction used in IVT 
 
In this case, total RNAi = 7μg, y = 1. 
2.12.1.6 Fragmenting the cRNA  
Sample cleanup module was used for cRNA fragmentation. cRNA that after 
cleanup was fragmented by mixing 8 μl of 5 × fragmentation buffer per 20 μg adjusted 
cRNA and top up with RNase-free water to a final volume of 40 μl. The fragmentation 
buffer is able to break down full-length cRNA to 35 to 200 base fragments by metal-
induced hydrolysis. The mixture was then incubated at 94˚C for 35 min and placed on ice 
following incubation. Fragmented cRNA was verified by gel electrophoresis (section 
2.12.1.2). 
2.12.2 Target hybridization 
Ten Affymetrix murine genome arrays U74A (Affymetrix, Santa Clara, CA) 
containing probe sets presenting all known mouse genes and 6000 ESTs were used for 
this study. Two chips were used for 8-hour control while three chips for 24-hour control. 
The remaining chips were for both 8-hour (n=2) and 24-hour (n=3) treatment. In addition, 
ten GeneChip Test3 arrays (Affymetrix) were also used to check the quality of the targets 
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and the labeling efficiency before analysis on the actual U74A microarrays. Each Test3 
array contains probe sets representing a subset of characterized genes from various 
organisms as well as a subset of human and mouse housekeeping genes. 
2.12.2.1 Reagent preparation for target hybridization 
12 × MES Stock Buffer (1.22 M MES, 0.89 M [Na+]) 
MES hydrate (Sigma-Aldrich) 64.61 g 
MES sodium salt (Sigma-Aldrich) 193.3 g 
Water to a final volume of 1000 ml 
The pH should be between 6.5-6.7. Filter through a 0.2 μm filter. Store at 2˚C to 
8˚C, and shield from light. 
 
2 × Hybridization Buffer  
(200 mM MES, 2 M [Na+], 40 mM EDTA, 0.02% Tween-20) 
12 × MES Stock Buffer 8.3 ml 
5 M NaCl (Ambion) 17.7 ml 
0.5 M EDTA (Sigma-Aldrich) 4.0 ml 
10% Tween-20 (Pierce Chemical) 0.1 ml 
Water to a final volume of 50 ml 
Store at 2˚C to 8˚C, and shield from light. 
 
2.12.2.2 Hybridization 
For gene expression analysis on an array, a hybridization cocktail containing 15 μg 
of fragmented cRNA was prepared as follow: 
Components Volume (μl) 
Fragmented cRNA For 15 μg 
3 nM Control Oligonucleotide B2 (Affymetrix) 5 
20 × Eukaryotic Hybridization Controls (bioB, bioC, 
bioD, cre) (Affymetrix) 15 
10 mg/ml Herring Sperm DNA (Promega Corporation) 3 
50 mg/ml BSA (Invitrogen Life Technologies) 3 
2 × Hybridization Buffer (Affymetrix) 150 
DMSO (Sigma) 30 




The cocktail was heated to 99˚C for 5 min and spun at maximum speed for 5 min. At the 
same time, the array was hydrated with 1 × hybridization buffer (100 μl for Test3 array; 
250 μl for U74A chip) at 45˚C for 10 min with rotation (60 rpm). Later, the hybridization 
buffer was removed from the array and the hybridization cocktail (80 μl for Test3 array; 
200 μl for U74A chip) was hybridized to the hydrated array 16 h at 45˚C with rotation (60 
rpm).  
2.12.3 Washing and staining of hybridized arrays 
Reagents for washing and staining of the hybridized array were prepared as 
followed: 
2 × Stain Buffer 
(200 mM MES, 2 M [Na+], 0.1% Tween-20) 
12 × MES Stock Buffer 41.7 ml 
5 M NaCl 92.5 ml 
10 % Tween-20 2.5 ml 
Water To a final volume of 250 ml 
Filter through a 0.2 μm filter. Store at 2˚C to 8˚C and shield from 
light. 
 
Streptavidin Phycoerythrin (SAPE) Stain Solution (for a single array) 
2 × Stain Buffer 600 μl 
50 mg/ml acetylated BSA 48 μl 
1 mg/ml SAPE (Molecular Probes, Eugene, OR) 12 μl 
DEPC-treated water 540 μl 
Prepare the SAPE solution on the day of use. Mix well and divide into two aliquots of 
600 μl each to be used for stains 1 and 3. 
 
Antibody Solution (for a single array) 
2 × Stain Buffer 300 μl 
50 mg/ml acetylated BSA 24 μl 
10 mg/ml Goat IgG (Vector Laboratories) 6 μl 
0.5 mg/ml biotinylated antibody (Vector Laboratories, 
Burlingame, CA) 3.6 μl 
DEPC-treated water 266.4 μl 
Total  600 μl 
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After 16 h of hybridization, the cocktail was removed and Test3 arrays were filled 
manually with 100 μl Wash A [6 × SSPE (BioWhittaker Molecular Applications / 
Cambrex) and 0.01% Tween-20] while U74A chips were filled with 250 μl Wash A. 
Subsequent staining of hybridized arrays were done automatically using the Affymetrix 
Fluidics Station 400 operated with GCOS/Microarray Suite. Micro_1v1 Fluidics protocol 
was selected for the Test3 arrays while the EukGE-WS2 Fluidics protocol was selected 
for the U74A GeneChips as table below.  
 Micro_1v1 EukGE-WS2 
 
Post Hyb  
Wash #1 
 





8 cycles of 15 mixes/cycle 
with Wash B (100 mM MES, 0.1 
M [Na+], 0.01% Tween-20) at 
50˚C. 
4 cycles of 15 mixes/cycle 




The probe array was stained for 10 min in SAPE stain solution at 25˚C. 
 
Post Stain  
Wash 
 









The probe array was stained for 10 min in SAPE stain solution at 25˚C 
Final Wash 15 cycles of 4 mixes/cycle with Wash A at 35˚C. The holding temperature was 25˚C. 
 
2.12.4 Probe array scan and data analyses 
  The probe array was scanned using G2500A GeneArray Scanner (Agilent 
Technologies, Palo Alto, CA) after the wash protocol was complete. The scanner was also 
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controlled by Affymetrix Microarray Suite. The arrays were scanned with pixel value of 3 
μm and wavelength 570nm. 
The data from each array were collected and initially analyzed using Affymetrix 
Microarray Suite 5.0 software. The quality of the array data was considered as good if the 
flowing parameters were met: 3’/5’ signal ratio of actin less than 1.5; 3’/5’ signal ratio of 
GAPDH between 0.82 and 0.98. For comparison of multiple arrays, the signal intensity of 
each array was scaled to 500 and the relative mRNA expression levels were expressed as 
signal log ratios compared to controls. Genes which showed a change of 2-fold or more 
with a p-value of <0.05 were identified using GeneSpring and were included in 
subsequent statistical analysis. Functional information about each gene product was 
obtained from direct search of the primary literature and from web-based applications 
DAVID and NetAffx.  
 
2.13 ATP AND GSH MEASUREMENT 
 Cells were washed 2 × PBS (0.5 ml/well) and incubated with 6.5% TCA (50 
μl/well) on ice for 10 min. The supernatant from 4 wells was then transferred to a pre-
chilled 1.5 ml appendorf tube for both ATP and GSH measurement. After removal of the 
supernatant, 50μl of 1 M NaOH were added into each well and left for 3 h at room 
temperature to dissolve the proteins. Then, the solubilized proteins were collected and 
protein concentration was measured (section 2.7.2).  
ATP measurement was done as previously described (Kalbhen and Kock, 1967). 3 
μl of previously harvested supernatant were transferred into a white 96-well plate and 
incubated with 200 μl sodium arsenite ATP buffer (26.67 mM MgSO4.7H2O, 3.33 mM 
KH2PO4, 33.33 mM Na2HASO4.7H2O, adjust to pH 7.4 using 500 mM KH2PO4) and 10 
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μl filtered firefly lantern extract (Sigma). Luminescence was measured using LMax 
luminescence (Molecular Devices, Sunnyvale, CA).  For GSH measurement, 7.5 μl of 
standards and TCA-lysed cell extract was added into the wells of a black 96-well plate 
and followed by the addition of 277.5 μl 100 mM KH2PO4-KOH buffer and 15 μl 1 
mg/ml o-phthaldialdehyde in absolute methanol (Hissin and Hilf, 1976). After incubation 
for 25 min at room temperature in dark, the fluorescence were measured with fluorometer 
(Gemini XS spectrofluorometer, Molecular Devices) equipped with a 350-nm excitation 
filter and 420-nm emission filter. The relative amount of ATP and GSH in each sample 
was then compared to control after normalized for protein content.  
 
2.14 STATISTICAL ANALYSES 
Results were presented as mean ± SE. All experiments were performed at least 
three times. Data were analyzed using Tukey test with one-way analysis of variance 
(ANOVA) to determine significant differences in multiple comparisons. Values of *p < 





















CHAPTER 3  















In many settings of CNS abnormalities, for instances AD, ALS, PD and HD, 
neurons in the cerebral cortex are very sensitive. Therefore, the present study was carried 
out on cortical neurons. Cerebral cortical neurons were obtained from embryonic day 15 
or 16 Swiss-white mice after micro-dissection and enzymatic digestion, and were cultured 
in serum- and phenol red-free medium for DIV5 prior to use (section 2.1). This chapter 
covers the conditions and concentrations that required for apoptosis induced by HOCl in 
neurons. 
 
3.2 Treatment of HOCl causes concentration-dependent cell injury  
HOCl oxidizes methionine to form methionine sulfoxide (Tsan and Denison, 1981; 
Joppich-Kuhn et al., 1982) and also reacts with various amines to form chloramines 
(Weiss et al., 1983). Therefore, methionine and various amines in culture medium will 
serve as scavengers of HOCl and will attenuate HOCl-induced cell injury. To study the 
effect of HOCl in cortical neurons, cells were treated with HOCl in EBSS for 3 h and later 
incubated in fresh culture medium. HOCl decreases cell viability in a concentration-
dependent manner with at least 200 μM was needed to induce significant cell injury as 












Figure 3.1: HOCl decreases cell viability in a concentration-dependent manner.  
 
Neurons were treated with increasing dose of HOCl in EBSS for 3 h and cell viability 
determined after 24 h of HOCl treatment. Results were represented as percentage of 
control and means ± SE of at least three measurements per data point form three 







3.3 HOCl mediates apoptosis-necrotic continuum neuronal cell death 
Exposure of neuronal cells to HOCl resulted in concentration-dependent early 
release of LDH after a 3 h initial exposure (Fig. 3.2B). Within 3 h of intense insults (>300 
µM), almost all neurons were swollen compared to control (Fig. 3.2A; 1 mM HOCl) and 
none of the neurons appeared to possess apoptotic characteristics, such as shrinkage of 
neuronal cell body and condensation of nuclear chromatin confirmed by electron 
microscopy (Fig. 3.3B; 500 μM) indicating necrotic cell death in cortical neurons treated 
with >300 µM HOCl. In contrast, lower concentrations of HOCl (<300 µM) did not 
induce rapid cell swelling (Fig. 3.2A) and 24 h after exposure revealed typical signs of 
apoptosis including shrinkage of neuronal cell body and membrane bledding (Fig. 3.3A; 
Hoffman). Almost 100% of the population showed chromatin condensation when stained 
with Hoescht (Fig. 3.3A and C). Consistently, TEM revealed nuclei shrank and the 
chromatin strongly condensed when treated with 250 μM HOCl as compare to control in 
which neurons had oval-shaped nuclei characterized by an overall loose chromatin 
structure containing some dense spots (Fig. 3.3B). However, there was no fragmented 
chromatin under the nuclear envelope of 250 μM HOCl treated neurons as compared with 
STS treatment (Fig. 3.3B). Fluorescein isothiocyanate (FITC)-conjugated annexin V and 
propidium iodide (PI) stained cells displayed widespread annexin V-positive staining in 
intact plasma membrane (Fig. 3.3B). Taken together, HOCl causes necrosis in 




Figure 3.2: Necrotic cell death caused by high HOCl concentration.  
 
A, Hoffman photographs of neurons in different doses of HOCl treatment after 3 h. Scale 
bar = 20 μm. B, Changes in extracellular LDH levels in culture containing different HOCl 
concentrations after 3 h. Relative LDH levels were calculated as the percent of 0.1% triton 
X. Data are the means ± SE of at least three measurements per data point, from three 
independent experiments. * p < 0.05 compared with control. 
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Figure 3.3: Characterization of apoptosis by HOCl treatment after 24 h.  
 
A, Representation photographs of Hoffman and staining of Annexin V & PI as well as 
Hoescht 33342. Scale bar = 20 μm. B, Representative TEM pictures. The samples are 
neurons in control, HOCl, and staurosporine. Scale bar = 4 μm. C, Quantitative 
comparison of specifically stained cell population for Hoescht 33342. Data are the means 































After the establishment of an appropriate culture condition, the underlying 
mechanisms of HOCl-mediated apoptosis are addressed in this chapter. The involvement 
of caspases and caspase-independent mechanisms including calpain activation and 
lysosomal pathway were examined.  
 
4.2 Caspase involvement in HOCl-induced apoptosis 
Apoptosis mediated by activation of caspases is a major mechanism of neuronal 
death and caspase-3 is the essential executioner caspase. Using anti-caspase-3 antibody, 
which recognized the inactive pro-caspase as well as the activated fragment, the 
expression of the caspase were examined in HOCl-treated cultures (Fig. 4.1). As positive 
controls, the effect of STS and colchicine on caspase-3 activation was also examined. 
When neuronal cultures were exposed to STS (0.5 μM) and colchicine (0.1 μM) for 24 h, 
a 17-kDa cleaved fragment of caspase-3 was observed (Fig. 4.1). In contrast, no cleaved 
fragment of caspase-3 was seen in HOCl-treated cultures (Fig. 4.1). These results 
excluded the possibility of an effect of HOCl on caspase-3 activation in cortical neurons.  
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Figure 4.1: Time course of caspase-3 activation by immunoblot analysis.  
 
Protein lysates (15 μg per lane) were run on a 12% gel and transferred to PVDF 
membrane for the subsequent detection using anti-caspase-3 and anti-tubulin antibody. 
Col, colchicine.  
 
 
To examine in greater detail the caspases activated during HOCl-induced cell 
death, we charted the temporal changes in the activities of caspase-1, -2, -3, -6, -8, -9 and 
-10 over the course of 24 h after HOCl, STS and colchicine treatments, and the results are 
shown in figure 4.2. We found that STS and colchicine significantly elevated caspase-2, -
3, -6 and -10 activities. Unlike STS and colchicine, HOCl had no effect on caspase 
activity (Fig. 4.2). These results suggested that the neurotoxicity induced by HOCl was 




Figure 4.2: Temporal changes of caspases activity measured by fluorogenic 
substrates after HOCl treatment.  
 
Fluorescence intensity was expressed as relative fluorescence unit per μg protein. All data 
are the means ± SE of at least three measurements per data point, from three independent 





Consistent with results from fluorogenic assay, we found that active caspases measured by 
fluorochrome-labeled inhibitors of caspases (FLICA) were found in situ only in STS and 
colchicine-treated but not HOCl-treated cultures (Fig. 4.3). Thus, all the results obtained 
support the notion that caspase activation was not involved in HOCl-mediated neuronal 
cell death.   
 
Figure 4.3: In situ measurement of caspase activation using FLICA staining after 24 
h treatment.  
 
Representative photographs of neurons in control, HOCl (250 μM), Col (0.1 μM), and 
STS (0.5 μM). Scale bar = 20 μm.  
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4.3 HOCl stimulates calpain activation and calpain inhibitors provide protection 
against HOCl-induced cell death 
Activation of calcium-dependent proteases such as calpains has been shown 
playing an important role in neuronal death (McCollum et al., 2002; Neumar et al., 2003; 
Rami et al., 2003) and calpain inhibitors have been used to block apoptosis (McGinnis et 
al., 1998; Rami et al., 2000). However, to date, little is known about the involvement of 
calpains in HOCl-mediated cell death. Cleavage of α-fodrin leading to formation of 
145/150 kDa fragments is a well-recognised marker for the calpain-generated protein 
breakdown (Martin et al., 1995; Pike et al., 1998; Dutta et al., 2002). Immunoblot 
analysis of cleaved α-fodrin protein was utilized to examine HOCl-induced alteration of 
calpain activity. As shown in figure 4.4A, treatment with HOCl for 24 h led to a time-
dependent increase in α-fodrin proteolysis, accompanied by formation of the typical 
fragment of 145/150 kDa.  It should be noted that levels of 120 kDa α-fodrin fragment, 
know to be generated by caspase-3-induced cleavage (Wang et al., 1998), remained 
unchanged until 24 h of treatment with HOCl. In contrast, caspase-3 generates 120 kDa α-
fodrin fragments were observed in neurons undergoing apoptosis triggered by STS and 
colchicine.   
To explore a possible involvement of calpain-regulated pathway in HOCl-induced 
neuronal death, the effects of two calpain inhibitors on survival of HOCl-treated cortical 
neuronal cultures were examined. Treatment with cell-permeable calpain inhibitors 
(SJA6017 and calpeptin) markedly enhanced viability of cortical neurons exposed to 
HOCl, as shown by MTT assay (Fig. 4.4C). It should be noted that application of the 
same dose (10 μM) of the calpain inhibitors also abolished the accumulation of the 
calpain-specific 145/150 kDa α-fodrin breakdown product (Fig. 4.4B). Altogether, the 
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data indicate that HOCl-induced neuronal apoptosis is indeed dependent on the activation 
of calpains.  
 
 
Figure 4.4: Calpain activation and HOCl-induced cell death.  
 
A, Time dependent changes of α-fodrin cleavage in HOCl-treated neuronal cultures 
analysed by immunoblot. B, Effect of calpain inhibitors on α-fodrin cleavage. Protein 
lysates (15 μg per lane) were ran on 6 % gel and transferred to PVDF membrane for the 
subsequent detection using anti-α-fodrin and anti-tubulin antibody. C, Cell viability was 
measured by MTT reduction after 24 h. Cells were either untreated, treated with HOCl 
(250 μM) or with calpain inhibitor (SJA6017 or calpeptin, 10 μM). Results were 
represented as percentage of control. All data are the means ± SE of at least three 







4.4 Intracellular Ca2+ levels are increased in HOCl-treated cortical neurons 
Given that increase in intracellular Ca2+ concentration is an absolute requirement 
for calpain activation, imaging analysis using the cell-permeable fluorescent indicator 
Fura2-AM was employed for assessment of cytoplasmic free Ca2+ concentration ([Ca2+]i) 
after HOCl treatment. As shown in figure 4.5A, acutely applied HOCl can produced 
exponential and long-lasting elevation of [Ca2+]i. The fold change was 4 as compared to 
untreated cells (Fig. 4.5B).  
 
 
Figure 4.5: Acutely applied HOCl provokes [Ca2+]i changes. 
 
A, Representative graph showing ratio of fluorescence (Fura-2) measured in cell bodies of 
cultured cortical neurons. The HOCl was added at a concentration of 250 μM. At the 
beginning of the experiment, the cells were bathed in EBSS. HOCl was applied where 
indicated and it provoked a sustained augmentation of [Ca2+]i. B, Bar chart displaying the 
average [Ca2+]i of both control and HOCl-treated cultures. Data are the means ± SE of n = 





4.5 Extracellular and intracellular pools are sources for elevated Ca2+ 
In order to evaluate the source of Ca2+ for cell injury, MTT reduction was 
analyzed in the presence of EGTA (1 mM) and various Ca2+ channel blockers.  
Extracellular Ca2+ pool is derived from the culture medium, whereas, ER is the principal 
intracellular Ca2+ pool. Upon ER stress, Ca2+ from ER pool is released via two types of 
receptor/channels: the ryanodine receptor (RyR) and the inositol 1,4,5-trisphosphate 
receptor (IP3R). Removing extracellular Ca2+, chelating it with EGTA, significantly 
prevents cell death and the formation of 145/150 kDa α-fodrin fragment induced by HOCl 
treatment (Fig. 4.6). Nifedipine, a blocker of L-type Ca2+ channels, partially but 
significantly suppressed the HOCl-induced cell death (Fig. 4.6A). Surprisingly, both 
dantrolene (a selective blocker of RyR) and flufenamic acid (IP3R inhibitor) can also 
completely reversed cell death induced by HOCl (Fig. 4.6A). Therefore, it seems that both 


















Figure 4.6: Effect of Ca2+ channel antagonists and chelator on HOCl-induced cell 
death in cultured cortical neurons.  
 
A, Cells were incubated with control medium, with HOCl (250 μM) alone or containing 
EGTA (1 mM), nifedipine (10 μM), flufenamic acid (40 μM), and dantrolene (10 μM). 
After 24 h, viabilities were determined using MTT assay; data represent means ± SEM of 
three determinations (P<0.05). B, The effect of EGTA on HOCl-induced α-fodrin 
cleavage. Protein lysates (15 μg per lane) were ran on 6 % gel and transferred to PVDF 







4.6 Rupture of lysosomes followed calpain activation 
The changes of lysosomal membrane stability were examined using the 
lysosomotropic fluorescence probe, AO, which freely enters and accumulates in the acidic 
compartments of living cells. AO emits a red fluorescence, under UV excitation, only if it 
has been protonated. This property can be exploited to reveal impairments of the 
lysosomal proton gradient (Zdolsek et al., 1990). In control cells, AO was found as red 
granules localized in the cytoplasm with a perinuclear distribution consistent with that of 
lysosomes, together with some faint green staining of the nucleoli. The treatment with 
HOCl apparently disrupted the acidic properties of lysosomes and thereby AO relocation 
after 6 h as there was a lower intensity of red fluorescence and yellow and green halo that 
seemed to smear into cytoplasm (Fig. 4.7). This occurred in parallel with the formation of 
calpain-mediated α-fodrin fragment (Fig. 4.4A). Relocation of AO in HOCl-treated 
neurons can be prevented by calpeptin and SJA6017 (Fig. 4.7). Guanabenz was used as a 
lysosomal stabilizer (Choi et al., 2002) to indicate that AO relocation indeed associated 
with lysosomal destabilization, suggesting that calpain activation preceded and provoked 













Figure 4.7: Effects of calpain inhibitors and imidazoline drug on HOCl-induced 
lysosomal destability.  
 
Cells were untreated or treated with HOCl alone or HOCl with calpain inhibitors 
(SJA6017 and calpeptin, 10 μM) as well as guanabenz (5 μM) for 6 h. Cells were then 







4.7 HOCl-induced apoptosis is rescued by inhibitors of cathepsins D and L 
The rupture of lysosomes suggested that cathepsins could be released from the 
lysosomes to the cytosol. Thus, we assayed the protective ability against HOCl of 
pepstatin A, CA-074 Me, z-FF-FMK, or z-FL-COCHO, that are, respectively, specific 
inhibitors of cathepsin D, B, L and S.  Pepstatin A and z-FF-FMK conferred significant 
protection against HOCl neurotoxicity, whereas CA-074 Me and z-FL-COCHO did not 
reduce cytotoxicity measured by MTT assay (Fig. 4.8). These results suggested that 
cathepsin D and L might required for HOCl-induced apoptosis. 
 
 
Figure 4.8: Effect of cathepsin inhibitors on HOCl-induced neurotoxicity.  
 
HOCl-treated cells were incubated together with various cathepsin inhibitors. Cell 
viability was measured by MTT reduction after 24 h. Results were represented as 
percentage of control. All data are the means ± SE of at least three measurements per data 















APOPTOTIC AND SURVIVAL MECHANISMS INDUCED BY 













With the use of microarray techonology, the alteration of gene expression from 
HOCl-treated neurons can be rapidly obtained and analyzed. In this chapter, a list of 
significant altered genes after HOCl treatment (except genes with unknown function) was 
provided. An interpretation and summary of gene alteration in relation with apoptosis and 
cellular defenses was also included.  
 
5.2 Differentially expressed genes upon HOCl treatment  
Gene expression profiles were obtained for cortical neurons treated with 250 μM 
HOCl for 8 and 24 h. Microarray analysis with mRNA fold change greater than 2.0 for at 
least one time point were selected as differentially regulated genes. 277 genes were 
identified as HOCl responsive genes and they were classified into functional groups as 
described in section 2.12.4. It is recognized that a given gene may be assigned to more 
than one function or biological pathway. This may result in overestimation of the true size 
of each functional group. This was overcome by assignment to each gene a single 
functional class (Table 5.1). Figure 5.1 summarizes the global screening of gene 
expression analysis of 250 μM HOCl treatment, most of them clustered mainly in 
biological processes involving transcription regulation, cell cycle, development and 
differentiation, signal transduction, and transport. Furthermore, the differences between 
up-regulated and down-regulated genes for both 8-hour and 24-hour treatment were 
displayed (Fig. 5.2). As shown in figure 5.2A, major gene up-regulation was observed in 
cell death and response to stress. With respect to differentially down-regulated genes, they 
mainly grouped under cell cycle and ATP-dependent processes including lipid 
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metabolism, signal transduction and transport (Fig. 5.2B). Basically, most of the 
























Table 5.1: Differentially expressed genes in HOCl treatment.  
 
Genes were clustered into groups by biological function. The mean fold-change of each 
gene in HOCl-treated samples relative to control samples as well as the standard error, 
gene symbol and GenBank accession number were indicated. Each gene was assigned a 
single category to avoid overestimation of the true size of each functional group. Genes 
with unknown biological processes were not listed.  
Gene bank Symbol Gene name         Fold change 
Cell death  8 h 24 h 
AJ224738 Cradd CASP2 and RIPK1 domain containing adaptor with death domain -2.11 ±0.36 1.18 ±0.26 
AV138783 Gadd45b growth arrest and DNA-damage-inducible 45 beta 15.47 ±0.82 6.97 ±0.41 
AF055638 Gadd45g growth arrest and DNA-damage-inducible 45 gamma 3.02 ±0.35 1.61 ±0.20 
X16995 Nr4a1 nuclear receptor subfamily 4, group A, member 1 9.86 ±0.68 1.08 ±0.22 
M21050 Lyzs lysozyme 3.10 ±0.55 5.00 ±0.75 
X51547 Lzp-s P lysozyme structural 5.98 ±0.54 8.17 ±0.66 
AI853714 Ctsb cathepsin B 2.46 ±0.35 1.74 ±0.27 
AJ223208 Ctss cathepsin S 2.48 ±0.26 3.67 ±0.38 
AJ242663 Ctsz cathepsin Z 2.44 ±0.36 3.79 ±0.30 
AB013819 Birc5 baculoviral IAP repeat-containing 5 -1.15 ±0.35 -3.76 ±0.26 
L41495 Pim2 serine-threonine protein kinase -2.32 ±0.35 1.12 ±0.37 
AV373612 Bag3 Bcl2-associated athanogene 3 5.53 ±0.62 2.89 ±0.33 
D14077 Clu clusterin 2.05 ±0.35 1.72 ±0.25 
AI848868 Cd47 CD47 antigen  -2.88 ±0.35 -1.89 ±0.28 
AI839109 Tnfaip8 tumor necrosis factor, alpha-induced protein 8 -2.99 ±0.35 1.39 ±0.26 
       
Cell cycle     
D83745 Btg3 B-cell translocation gene 3 2.22 ±0.36 1.24 ±0.28 
AF002823 Bub1 budding uninhibited by benzimidazoles 1 homolog  1.29 ±0.35 -7.43 ±0.27 
M38724 Cdc2a cell division cycle 2 homolog A  1.17 ±0.35 -2.70 ±0.25 
AW061324 Cdc20 cell division cycle 20 homolog  1.17 ±0.36 -2.07 ±0.27 
L16926 Cdc25c cell division cycle 25 homolog C  -1.20 ±0.35 -2.82 ±0.28 
AJ223087 Cdc6 cell division cycle 6 homolog  -1.23 ±0.35 -2.08 ±0.27 
AI606257 Cdca7 cell division cycle associated 7 -2.17 ±0.35 -3.14 ±0.25 
AF012710 Cenpa centromere autoantigen A -1.29 ±0.35 -2.08 ±0.25 
X75483 Ccna2 cyclin A2 -1.23 ±0.35 -2.50 ±0.26 
X64713 Ccnb1 cyclin B1 -1.12 ±0.35 -5.52 ±0.25 
U09507 Cdkn1a cyclin-dependent kinase inhibitor 1A (P21) 1.30 ±0.35 2.01 ±0.32 
L11316 Ect2 ect2 oncogene 1.33 ±0.36 -2.45 ±0.26 
AB003503 Gspt2 G1 to phase transition 2 -2.21 ±0.35 1.10 ±0.25 
D86725 Mcm2 minichromosome maintenance deficient 2 mitotin -1.41 ±0.3 -2.21 ±0.26 
AA275196 Nusap1 nucleolar and spindle associated protein 1 1.35 ±0.35 -2.98 ±0.26 
U01063 Plk1 polo-like kinase 1  1.00 ±0.35 -3.23 ±0.30 
AA856349 Prc1 Protein regulator of cytokinesis 1 -1.25 ±0.35 -3.35 ±0.26 
AW121294 Rhou ras homolog gene family, member U -4.93 ±0.35 -1.30 ±0.33 
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Table 5.2: Differentially expressed genes in HOCl treatment. (Cont’d) 
 
Gene bank Symbol Gene name         Fold change 
Response to stress  8 h  24 h 
AW050387 Aldh1a3 aldehyde dehydrogenase family 1, subfamily A3 -1.57 ±0.37 2.16 ±0.38 
AA822174 Dhrs8 dehydrogenase/reductase (SDR family) member 8 1.33 ±0.35 3.17 ±0.26 
U12961 Nqo1 NAD(P)H:quinone oxidoreductase 1 2.60 ±1.24 4.07 ±0.29 
U24428 Gstm5 glutathione S-transferase, mu 5 2.08 ±0.35 1.27 ±0.25 
U95053 Gclm glutamate-cysteine ligase , modifier subunit 2.44 ±0.39 2.41 ±0.21 
M12571 Hsp70 heat shock protein 70 14.65 ±0.76 11.90 ±0.30 
AW046006 Dnajc10 DnaJ (Hsp40) homolog, subfamily C, member 10 -2.55 ±0.35 -1.14 ±0.27 
U50631 Hrsp12 heat-responsive protein 12 1.61 ±0.35 2.11 ±0.32 
AW124318 St13 suppression of tumorigenicity 13 2.34 ±0.35 1.41 ±0.16 
X56824 Hsp32 heat shock protein 32 5.14 ±0.35 3.36 ±0.28 
D50527 Ubc ubiquitin C 2.22 ±0.35 1.46 ±0.25 
AI843795 Pgls 6-phosphogluconolactonase 2.07 ±0.35 1.11 ±0.25 
      
Carbohydrate metabolism    
AI649125 Uxs1 UDP-glucuronate decarboxylase 1 -3.56 ±0.37 -1.02 ±0.26 
AB027012 Galk1 galactokinase 1 1.53 ±0.35 2.06 ±0.26 
J05277 Hk1 hexokinase 1 2.04 ±0.35 1.37 ±0.25 
M32599 Gapdh glyceraldehyde-3-phosphate dehydrogenase 2.17 ±0.35 1.10 ±0.25 
      
Lipid biosynthesis     
AI839286 Lrp10 low-density lipoprotein receptor-related protein 10 -2.10 ±0.35 1.10 ±0.27 
AW122523 Elovl6 ELOVL family member 6, elongation of long chain fatty acids  -1.60 ±0.35 -2.34 ±0.25 
AV068306 Ptdss1 phosphatidylserine synthase 1 -1.58 ±0.36 -2.52 ±0.27 
AA619207 Acsl4 acyl-CoA synthetase long-chain family member 4 -1.07 ±0.35 -2.13 ±0.27 
AF017175 Cpt1a carnitine palmitoyltransferase 1a, liver 1.05 ±0.35 2.03 ±0.32 
M35797 Acat2 acetyl-Coenzyme A acetyltransferase 2 1.23 ±0.35 -2.20 ±0.26 
AI848668 Sc4mol sterol-C4-methyl oxidase-like 1.42 ±0.35 -2.62 ±0.26 
AW049778 Mvd mevalonate (diphospho) decarboxylase 1.09 ±0.35 -3.06 ±0.25 
AW045533 Fdps farnesyl diphosphate synthetase 1.47 ±0.35 -2.94 ±0.26 
AW106745 Nsdhl NAD(P) dependent steroid dehydrogenase-like 1.68 ±0.35 -2.76 ±0.26 
AA716963 Idi1 isopentenyl-diphosphate delta isomerase 1.74 ±0.35 -2.81 ±0.27 
AB016248 Sc5d sterol-C5-desaturase homolog  2.11 ±0.36 -1.55 ±0.26 
      
Organic acid metabolism    
Z49976 Gad1 glutamic acid decarboxylase 1 -2.05 ±0.35 -2.91 ±0.25 
M31690 Ass1 argininosuccinate synthetase 1 -2.18 ±0.36 1.43 ±0.26 





-1.50 ±0.35 -3.03 ±0.27 
AJ130975 Arih2 ariadne homolog 2 2.23 ±0.35 2.30 ±0.25 
 
 80
Table 5.3: Differentially expressed genes in HOCl treatment. (Cont’d) 
 
Gene bank Symbol Gene name         Fold change 
Development and differentiation 8 h 24 h 
X82786 Mki67 antigen identified by monoclonal antibody 
Ki 67 -1.26 ±0.36 -10.97 ±0.26 
AJ243964 Dkk3 dickkopf homolog 3  2.31 ±0.35 1.82 ±0.26 
AW123921 Dab2 disabled homolog 2  -3.11 ±0.41 1.27 ±0.27 
U07602 Efnb1 ephrin B1 -2.18 ±0.35 -1.25 ±0.25 
AI849615 Gas5 growth arrest specific 5 2.28 ±0.35 1.60 ±0.26 
L12447 Igfbp5 insulin-like growth factor binding protein 5 -1.19 ±0.35 -2.05 ±0.26 
AA220427 Jarid1b jumonji, AT rich interactive domain 1B (Rbp2 like) -2.23 ±0.35 -1.19 ±0.27 
Y00864 Kit kit oncogene -2.74 ±0.35 -1.67 ±0.27 
X92397 Ndph Norrie disease homolog -2.64 ±0.35 -1.14 ±0.25 
Z11886 Notch1 Notch gene homolog 1  -2.23 ±0.35 -1.33 ±0.26 
AA738776 Pspc1 paraspeckle protein 1 1.44 ±0.35 2.29 ±0.26 
AI425994 Repin1 replication initiator 1 -2.16 ±0.35 -1.06 ±0.29 
U69535 Sema4d 
sema domain, immunoglobulin domain (Ig), 
transmembrane domain (TM) and short 
cytoplasmic domain, (semaphorin) 4D 
-2.25 ±0.35 1.54 ±0.26 
D32167 Zic1 Zic family member 1  -1.59 ±0.36 -2.16 ±0.25 
M12848 Myb myeloblastosis oncogene -2.32 ±0.40 -4.30 ±0.27 
L35261 Mybl1 myeloblastosis oncogene-like 1 2.15 ±0.38 1.18 ±0.27 
      
Immune/inflammatory response    
X68273 Cd68 CD68 antigen 1.51 ±0.35 2.56 ±0.22 
L08115 Cd9 CD9 antigen 2.55 ±0.35 1.91 ±0.26 
X52490 H2-D1 histocompatibility 2, D region locus 1 2.00 ±0.35 1.67 ±0.26 
M27034 H2-K1 histocompatibility 2, K1, K region 2.16 ±0.36 1.66 ±0.26 
X16202 H2-Q7 histocompatibility 2, Q region locus 7 1.92 ±0.35 2.02 ±0.23 
U43085 Ifit2 interferon-induced protein with tetratricopeptide repeats 2 -1.34 ±0.38 2.05 ±0.27 
X15986 Lgals1 lectin, galactose binding, soluble 1 1.40 ±0.35 2.33 ±0.26 
X16834 Lgals3 lectin, galactose binding, soluble 3 3.37 ±0.36 6.80 ±0.17 
      
Calcium-binding proteins    
X73985 Calb2 calbindin 2 -1.01 ±0.36 -2.17 ±0.26 
D26352 Calb1 calbindin 1 -1.37 ±0.35 -2.19 ±0.26 
X17320 Pcp4 Purkinje cell protein 4 1.26 ±0.35 -2.30 ±0.26 
X66449 S100a6 S100 calcium binding protein A6  1.11 ±0.36 3.09 ±0.46 
M16465 S100a10 S100 calcium binding protein A10  1.66 ±0.35 2.03 ±0.44 
AV293396 S100a14 S100 calcium binding protein A14 -2.07 ±0.35 -1.91 ±0.28 
U41341 S100a11 S100 calcium binding protein A11  -1.35 ±0.35 2.20 ±0.30 
      
DNA repair     
AI553463 Orc4l origin recognition complex, subunit 4-like -2.09 ±0.35 -1.21 ±0.27 
M14223 Rrm2 ribonucleotide reductase M2 -1.56 ±0.35 -3.13 ±0.25 
U01915 Top2a topoisomerase (DNA) II alpha -1.40 ±0.35 -4.06 ±0.25 




Table 5.4: Differentially expressed genes in HOCl treatment. (Cont’d) 
 
Gene bank Symbol Gene name         Fold change 
Nucleosome assembly  8 h 24 h 
X05862 Hist1h2bc histone 1, H2bc 3.85 ±0.35 2.47 ±0.24 
X90778 Hist1h2ba histone 1, H2ba 2.43 ±0.36 1.90 ±0.27 
M32459 Hist2h3c2 histone 2, H3c2 2.98 ±0.22 2.65 ±0.26 
AF040252 Fkbp7 FK506 binding protein 7 2.00 ±0.37 -1.09 ±0.28 
X67668 Hmgb2 high mobility group box 2 1.59 ±0.35 -2.25 ±0.26 
      
Transcription regulation    
AI853173 Rpo1-3 RNA polymerase 1-3 2.00 ±0.35 1.70 ±0.26 
U47543 Nab2 Ngfi-A binding protein 2 2.18 ±0.35 1.02 ±0.27 
M31885 Idb1 inhibitor of DNA binding 1 2.28 ±0.35 1.58 ±0.25 
M60523 Idb3 inhibitor of DNA binding 3 2.26 ±0.36 1.85 ±0.26 
U51000 Dlx1 distal-less homeobox 1 -2.30 ±0.35 -3.03 ±0.26 
U67840 Dlx5 distal-less homeobox 5 -1.77 ±0.35 -2.33 ±0.27 
L46855 Trim27 tripartite motif protein 27 -2.49 ±0.36 -1.06 ±0.27 
AJ001972 Idb4 inhibitor of DNA binding 4 -2.17 ±0.35 -1.25 ±0.26 
U19118 Atf3 activating transcription factor 3 3.11 ±0.35 2.12 ±0.25 
M59821 Ier2 immediate early response 2 7.49 ±0.38 1.94 ±0.39 
X67644 Ier3 immediate early response 3 3.49 ±0.35 2.94 ±0.29 
X14897 Fosb FBJ osteosarcoma oncogene B 5.17 ±0.35 1.30 ±0.26 
AF064088 Klf10 Kruppel-like factor 10 3.66 ±0.35 1.26 ±0.25 
X12761 Jun Jun oncogene 5.29 ±0.32 2.41 ±0.26 
V00727 Fos Mouse c-fos oncogene. 20.94 ±0.53 2.19 ±0.26 
U20344 Klf4 Kruppel-like factor 4  4.80 ±0.45 2.26 ±0.20 
AA673500 Taf9 TAF9 RNA polymerase II, TATA box binding protein (TBP)-associated factor 2.13 ±0.35 1.58 ±0.26 
U20282 Tcf20 transcription factor 20 2.07 ±0.36 1.15 ±0.26 
AB013357 Zfp207 zinc finger protein 207 2.00 ±0.35 -1.02 ±0.26 
AF079528 Ier5 immediate early response 5 -2.55 ±0.35 -1.29 ±0.26 
U29086 Neurod6 neurogenic differentiation 6 -2.26 ±0.35 1.11 ±0.25 
AF020200 Pbx3 pre B-cell leukemia transcription factor 3 -2.17 ±0.36 -1.70 ±0.26 
AI553024 Zfp145 zinc finger protein 145 -2.53 ±0.35 -2.13 ±0.25 
AI551347 Zfp467 zinc finger protein 467 -2.15 ±0.39 -1.17 ±0.27 
AW212708 Zfp322a zinc finger protein 322a -2.61 ±0.35 -1.67 ±0.27 
      
Signal transduction     
AI847399 Rgs10 regulator of G-protein signalling 10 -2.34 ±0.35 -1.81 ±0.29 
AW121438 Rgs19 regulator of G-protein signaling 19 -3.86 ±0.35 -1.13 ±0.26 
D21061 Gpr12 G-protein coupled receptor 12 -2.12 ±0.36 -1.39 ±0.27 
U32329 Ednrb endothelin receptor type B -1.01 ±0.35 -3.47 ±0.26 
U08354 Mc5r melanocortin 5 receptor -2.76 ±0.35 -1.44 ±0.28 
AV372577 Npy2r neuropeptide Y receptor Y2 -2.23 ±0.37 -1.31 ±0.26 
AJ132192 Hs1bp3 HS1 binding protein 3 -2.39 ±0.35 -1.10 ±0.27 
U56651 Nxph1 neurexophilin 1 -1.41 ±0.36 -2.96 ±0.26 
AF000236 Cmkor1 chemokine orphan receptor 1 -7.06 ±0.38 -1.75 ±0.25 
U88327 Socs2 suppressor of cytokine signaling 2 -2.33 ±0.35 -1.19 ±0.26 
U05245 Tiam1 T-cell lymphoma invasion and metastasis 1 -2.16 ±0.35 -1.41 ±0.27 
X86000 Siat8d sialyltransferase 8 (alpha-2, 8-sialyltransferase) D -2.69 ±0.37 -1.87 ±0.26 
AV365271 Nedd4 neural precursor cell expressed, developmentally down-regulted gene 4 3.02 ±0.35 1.43 ±0.26 
AF005423 Clk4 CDC like kinase 4 2.66 ±0.35 1.50 ±0.25 
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Table 5.5: Differentially expressed genes in HOCl treatment. (Cont’d) 
 
Gene bank Symbol Gene name         Fold change 
Signal transduction  8 h 24 h 
M86377 Ttk Ttk protein kinase -1.31 ±0.35 -2.90 ±0.26 
AV319920 Prkwnk1 protein kinase, lysine deficient 1 -1.61 ±0.35 -3.11 ±0.27 
AF036332 Nlk nemo like kinase -2.24 ±0.35 -1.36 ±0.26 
AA881294 Pxk PX domain containing serine/threonine kinase -2.93 ±0.35 1.00 ±0.27 
AA822531 Stk2 serine/threonine kinase 2 -2.02 ±0.35 -1.17 ±0.27 
X61940 Dusp1 dual specificity phosphatase 1 2.28 ±0.35 1.58 ±0.27 
AF013490 Ptpn9 protein tyrosine phosphatase, non-receptor type 9 -2.36 ±0.35 -1.05 ±0.29 
D83203 Ptprj protein tyrosine phosphatase, receptor type, J -2.22 ±0.35 -1.50 ±0.27 
D83484 Ptpre protein tyrosine phosphatase, receptor type, E -3.48 ±0.35 -1.10 ±0.28 
      
RNA processing     
U65316 Hnrpa1 heterogeneous nuclear ribonucleoprotein A1 2.07 ±0.35 1.01 ±0.28
AW049372 Sf3b1 splicing factor 3b, subunit 1 2.04 ±0.35 1.25 ±0.26
AA684508 Rnu22 U22 small nucleolar RNA 2.07 ±0.35 1.21 ±0.28
      
Protein synthesis    
AA600468 Eif2s2 eukaryotic translation initiation factor 2, subunit 2 (beta) 2.16 ±0.36 -1.23 ±0.27 
X06406 Lamr1 laminin receptor 1 (ribosomal protein SA) 2.19 ±0.35 1.20 ±0.25 
X15962 Rps12 ribosomal protein S12 2.04 ±0.35 1.33 ±0.25 
AW048899 Rps19 ribosomal protein S19 2.49 ±0.35 1.24 ±0.26 
Z54209 Rps6 ribosomal protein S6 2.11 ±0.40 1.20 ±0.25 
X73829 Rps8 ribosomal protein S8 2.31 ±0.35 1.20 ±0.26 
Z50159 Sui1-rs1 suppressor of initiator codon mutations, related sequence 1 2.16 ±0.35 -1.06 ±0.27 
      
Cell motility/cytoskeleton    
M13444 Tuba4 tubulin, alpha 4 -2.05 ±0.35 1.05 ±0.28 
X05640 Nef3 neurofilament 3, medium 2.78 ±0.35 1.90 ±0.57 
M55424 Nefl neurofilament, light polypeptide 2.17 ±0.35 1.44 ±0.40 
AW215736 Tubb6 tubulin, beta 6 2.22 ±0.35 2.04 ±0.28 
D88793 Csrp1 cysteine and glycine-rich protein 1 1.44 ±0.35 2.06 ±0.26 
AI155285 Eea1 early endosome antigen 1      -2.08 ±0.35 -1.30 ±0.26 
AJ223293 Kif11 kinesin family member 11 -1.78 ±0.35 -4.91 ±0.26 
AV059766 Kif20a kinesin family member 20A -1.31 ±0.35 -5.20 ±0.26 
AI591702 Kif23 kinesin family member 23 1.24 ±0.35 -3.88 ±0.27 
AA007891 Kif2c kinesin family member 2C -1.28 ±0.35 -3.08 ±0.26 
D12646 Kif4 kinesin family member 4 -1.40 ±0.35 -2.96 ±0.26 
AJ249706 Myo10 myosin X -2.31 ±0.35 -1.46 ±0.25 
D50032 Tgoln1 trans-golgi network protein 2.51 ±0.36 1.50 ±0.27 
      
Cell adhesion     
D45889 Cspg2 chondroitin sulphate proteoglycan 2 -2.11 ±0.36 -2.55 ±0.27 
X67279 Ceacam2 CEA-related cell adhesion molecule 1 -2.23 ±0.36 -1.59 ±0.27 
AI132491 Bysl bystin-like -2.41 ±0.35 -1.16 ±0.27 
AB001419 Gp1bb glycoprotein Ib, beta polypeptide 1.23 ±0.36 -2.26 ±0.27 
D28818 Epb4.1l4a erythrocyte protein band 4.1-like 4a -2.22 ±0.35 -1.20 ±0.25 
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Table 5.6: Differentially expressed genes in HOCl treatment. (Cont’d) 
 
Gene bank Symbol Gene name         Fold change 
Cell adhesion  8 h 24 h 
U00674 Sdc2 syndecan 2 -2.10 ±0.35 1.19 ±0.28 
X69902 Itga6 integrin alpha 6 -2.17 ±0.35 -1.33 ±0.26 
AI848508 Smoc1 SPARC related  modular calcium binding 1 -2.18 ±0.35 -1.95 ±0.27 
AB000636 Col19a1 procollagen, type XIX, alpha 1 1.55 ±0.36 -2.08 ±0.27 
AB018194 
 Ptpns1 
protein tyrosine phosphatase, non-receptor 
type substrate 1 -2.49 ±0.35 1.06 ±0.27 
U24703 Reln Reelin 1.01 ±0.35 -3.30 ±0.26 
      
Transport      
AI844507 
 Arfgap3 
ADP-ribosylation factor GTPase activating 
protein 3 -3.66 ±0.35 1.02 ±0.26 
U88623 Aqp4 aquaporin 4 2.15 ±0.35 -1.33 ±0.26 
AF103875 Abcg2 ATP-binding cassette, sub-family G (WHITE), member 2 1.10 ±0.35 2.22 ±0.26 
AF109905 Clic1 chloride intracellular channel 1 1.33 ±0.35 2.44 ±0.30 
U04710 Igf2r insulin-like growth factor 2 receptor -2.17 ±0.35 -1.18 ±0.27 
AI849601 Kcnk2 potassium channel, subfamily K, member 2 -2.66 ±0.35 -1.15 ±0.26 
AV367240 Kcnq1 potassium voltage-gated channel, subfamily Q, member 1 -2.16 ±0.35 -1.31 ±0.28 
AW049351 ank progressive ankylosis -2.15 ±0.35 -1.06 ±0.26 
D12713 Sec23a SEC23A  2.29 ±0.35 1.50 ±0.42 
AF072759 Slc27a4 solute carrier family 27 (fatty acid transporter), member 4 -2.11 ±0.35 -1.29 ±0.27 
AI837116 Slc41a1 solute carrier family 41, member 1 -2.14 ±0.36 1.16 ±0.26 
AW048729 Slc5a6 solute carrier family 5 (sodium-dependent vitamin transporter), member 6 -2.61 ±0.35 -1.88 ±0.27 
M92378 Slc6a1 solute carrier family 6 (neurotransmitter transporter, GABA), member 1 -2.45 ±0.35 -2.09 ±0.25 
AJ001598 Viaat Vesicular inhibitory amino acid transporter -2.14 ±0.35 -3.60 ±0.25 
AF029982 Atp2a2 ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 -2.09 ±0.35 -1.48 ±0.26 















Figure 5.1: Functional cluster analysis of genes involved in biological processes 
categorized according to Gene Ontology.  
 
Pie chart shows the distribution of HOCl responsive genes as compared to control. The 
number of altered genes in the different functional groups is indicated. The total number 







Figure 5.2: Comparison of HOCl affected biological processes between 8 h and 24 h 
treatment.  
 
Bar chart shows, A, distribution of up-regulated and B, down-regulated genes in HOCl 
samples compared to control.  
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5.3 Validation of microarray analysis 
Western blotting was used to validate results of the microarray analysis for 
selected genes including HSP70, ATF-3 and cell cycle proteins (cyclin D1 and D3) (Fig. 
5.3). Consistently, both microarray and western blot showed up-regulation of HSP70 and 
ATF-3 as well as repression of cell cycle proteins in HOCl-induced apoptosis.    
 
 
Figure 5.3: Protein expression of ATF-3, HSP70, and cell cycle proteins analyzed by 
Western blotting.  
 
15 μg proteins per lane were run on 12% gel and transfered to PVDF membrane for the 






5.4 HOCl induces changes on apoptosis-related genes expression 
Since HOCl induced apoptosis in cortical neurons, death-related genes would be 
significantly affected with apoptotic genes up-regulated while anti-apoptotic genes down-
regulated. Indeed, there was an increase in mRNAs of pro-apoptotic proteins Gadd45b, 
Gadd45g, Nr4a1, and lysosomal proteases such as Lyzs, Lzp-s, and cathepsin proteases 
(Kim et al., 2003; Rajpal et al., 2003; Mak and Kultz, 2004; Chintharlapalli et al., 2005). 
Negative regulators of apoptosis Pim2 and Birc5 were decreased in expression (Fox et al., 
2003; Kawamura et al., 2003). However, cell cycle genes known to be involved in 
apoptosis were down-regulated in HOCl-treated neurons with time. Furthermore, 
enhanced expression of the apoptosis-related transcription factors (Jun, Fos, Fosb and 
Klf10) and repressor of cell cyle genes (Klf4) were also observed (Ribeiro et al., 1999; 
Sastry and Rao, 2000; Shie et al., 2000; Chen et al., 2001; Yoon and Yang, 2004). 
 
5.5 HOCl stimulates stress response: maintenance of cellular redox state 
GSH depletion has previously been reported in early-phase of HOCl-treated cells 
(Vissers and Winterbourn, 1995; Carr and Winterbourn, 1997; Whiteman et al., 2002, 
2003). Ideally, in association with an increased utilization of GSH, there would also be an 
increased production of GSH. The rate-limiting step in the GSH biosynthesis is mediated 
by glutamate-cysteine ligase (GCL) (Liu et al., 2004). In this study, the modifier subunit 
of GCL was up-regulated and its up-regulation was correlated with an increase in GSH 
levels after 24 h treatment (Fig. 5.4). mRNA expression of some detoxifying enzymes 
Aldh1a3, Dhrs8, Nqo1 and Gstm5 and heat shock proteins (HSPs) were also augmented. 
The induction of the rate-limiting enzyme of NADPH-generating pathway (pentose 
phosphate pathway, PPP), Pgls, was also observed.  
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5.6 HOCl causes the salvage of energy: maintenance of cellular ATP level 
Oxidative stress leading to decrease in GSH availability contributes to the 
depletion of intracellular ATP level by targeting the electron transport chain containing 
many iron–sulfur (Fe–S) clusters (Jha et al., 2000). Therefore, ATP depletion was also 
another characteristic of HOCl-induced cell death (Fig. 5.4) (Whiteman et al., 2002, 2003, 
2005). To compensate the energy loss, glycolytic enzymes, Hk1 and Gapdh, were up-
regulated. Apart from glucose, other monosaccharides can also be funneled into glycolysis 
to supply energy, for example, galactose. Galactokinase 1, an enzyme functions in the 
Leloir pathway (Holden et al., 2003), was up-regulated. At the same time, reduction of 
gene expression of organic acid as well as lipid metabolism, and decrease of mRNA level 
of proteins associated with ATP-dependent transportation and signal transduction might 
also salvage the usage of energy. Taken as a whole, the striking down-regulation of genes 
involved in ATP-dependent processes and stimulation of glycolysis worked in parallel to 
















Figure 5.4: Effect of HOCl on cellular GSH and ATP content.  
 
Cortical neurons were treated with HOCl and harvested after 24 h. Intracellular GSH and 
ATP were analyzed in TCA lysed cells using o-phthaldialdehyde and lantern extract 
respectively. Data are expressed as Mean ± SE of 3 separate experiments. *p < 0.5 


































6.1 Introduction  
The significances of experiments done were provided and their disadvantages 
were discussed in this chapter.  
 
6.2 HOCl mediates concentration-dependent apoptosis-necrotic continuum neuronal 
cell death 
Treatment of cultured cortical neurons with high concentration of HOCl (>300 
μM) caused rapid cell swelling and release of LDH, demonstrating high doses of HOCl 
cause cell death by necrosis. Whereas, neurons treated with intermediate concentration of 
HOCl (200-300 μM) exhibited condensed nuclei, PS externalization on intact plasma 
membrane and shrinkage of cell body showing the occurrence of apoptosis. The ability of 
HOCl to induce apoptosis-necrotic continuum cell death is corroborated by other data 
(Vissers et al., 1999; Sugiyama et al., 2004). However, the concentration range of HOCl 
used in neuronal culture is higher (200 μM in primary neurons) than other non-neuronal 
cells for instance hepatocyte (Whiteman et al., 2005) and endothelial cells (Vissers et al., 
1999, 2001b; Sugiyama et al., 2004) in which necrosis was observed at 100 μM of HOCl 
(Table 6.1). This might be contributed by some dissimilarity on technical approaches. 
Before treated with HOCl, non-neuronal cells were washed few times with amine-free 
medium to minimize the carry-over of amine. However, neurons are too vulnerable so that 
washing with amine-free medium before HOCl treatment were unable to perform. In 
addition, HOCl-mediated injury to cells is dependent on the absolute amount of HOCl 
rather than its concentration (Vissers et al., 1994) and thereby the higher cell density and 
smaller volume of HOCl solution make the range of HOCl used greater than any other cell 
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Table 6.1: Comparison of HOCl amount required in various model system.  






0.5 × 106  All range of HOCl in 1 ml 
HBSS 




cell lines JLP-119 
and BL-41 
0.5 × 106  All range of HOCl in 1 ml 
PBS 




like cell line THP1; 
murine 
macrophage-like 
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6.3 Underlying mechanisms of neuronal apoptosis caused by HOCl 
Apoptosis is a ubiquitous cellular suicide program found in all multi-cellular 
organisms. Activation of caspase-3 appears to be a critical event in the execution of 
neuronal apoptosis in the brain during development and after injury. It has already been 
demonstrated that, after stimulation by HOCl the apoptotic cells showed caspase-3 
activation (Vissers et al., 1999; Sugiyama et al., 2004). Therefore, the mechanism of 
HOCl neurotoxicity has been assumed to be similar and might be caspase-dependent. In 
contrast with published data, we did not find evidence of caspase-3 activation after HOCl 
treatment. The lack of caspase-3 activation was confirmed by Western blot analysis and 
fluorogenic substrate cleavage. In addition, morphological characteristic of apoptotic 
cells that has been shown to require caspase-3 activity is the fragmentation of chromatin 
(Enari et al., 1998; Janicke et al., 1998; Woo et al., 1998). Neurons displayed this 
morphology when undergoing classical apoptosis triggered by STS, a caspase-3 
dependent apoptosis model but not in HOCl-induced cell death. Furthermore, HOCl 
treatment produced no caspase-3 specific 120 kDa α-fodrin fragment as STS and 
colchicine do. Therefore, neurons treated with HOCl displayed characteristics of an 
apoptosis-like death suggesting that caspase-3 is not the predominant execution protease 
in this apoptosis model. The possible involvement of other caspases, like caspase-1, -2, -
6, -8, -9 and -10, was also ruled out as their activations were not detected in the dying 
cells when assayed with fluorogenic substrates. Although there is possibility that another 
known mammalian caspase that was not assayed for is the cell-death executor in these 
cells, the results from FLICA staining are intriguing and suggestive of caspase-
independent cell death. The results obtained from microarray analysis do suggest HOCl-
mediated neuronal apoptosis is independent from caspases. Cradd which required for 
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caspase recruitment was found down-regulated. However, a nearly 10 folds upregulation 
of an orphan steroid receptor, Nr4a1, involved in caspase-independent cell death (Kim et 
al., 2003) after HOCl treatment was observed. The induction of Nr4a1 was showed to be 
calcium-dependent in T cells (Youn and Liu, 2000; Youn et al., 2000). It triggers 
apoptosis by translocation from nucleus to mitochondria where it binds Bcl-2 to form a 
pro-apoptotic complex which releases mitochondrial cell-death mediators such as 
cytochrome c and apoptosis-inducing factor (Lin et al., 2004; Maddika et al., 2005). 
Nr4a1 also activates transcription of E2F1 which is also pro-apoptotic (Mu and Chang, 
2003).  
Although caspase-mediated apoptosis is the principal program of cell death in 
many settings, it would be dangerous for an organism to depend on a single protease 
family for the clearance of unwanted and potentially harmful cells. Recent data indicate 
that programmed cell death can occur in the complete absence of caspases (Leist and 
Jaateela, 2001; Lockshin and Zakeri, 2002). The ability of some cells to survive the 
activation of pro-apoptotic caspases also indicates a diversification of the cellular death 
program and argues against the idea that caspases alone are sufficient for the induction of 
apoptosis (Zeuner et al., 1999; Leist and Jaattela, 2001). Calpains represent a class of 
cytosolic cysteine proteases activated by elevated intracellular Ca2+ concentrations. 
Under pathological conditions, calpains have been implicated in excitotoxic neuronal 
injury, hypoxia-ischemia brain injury and AD (Saito et al., 1993). Activation of the 
protease calpain has been shown to induce morphological changes in thrombocytes 
resemble a caspase-mediated apoptotic cell death, including exposure of PS on the outer 
plasma membrane and cell body shrinkage (Wolf et al., 1999). Therefore, the apoptosis-
like morphologies occur in HOCl-mediated neuronal cell death could be due to the 
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activation of calpain, rather than the activation of executioner caspases. The present study 
suggests an important role for calpain in cell death induced by HOCl. The calpain 
inhibitors, SJA6017 and calpeptin, showed significant protective effects on HOCl-
mediated cell death in cortical neuronal cultures and these inhibitors block cell death 
completely. Calpain activation therefore appears to be a crucial mechanism required for 
cell death in this model. In addition, HOCl stimulated calpain activity (i.e. α-fodrin 
cleavage) in cortical neurons; this effect was abolished by treatment with calpain 
inhibitors. Moreover, a significant increase in cytosolic Ca2+ concentration was observed 
right after the induction of HOCl at the single cell level. This elevated Ca2+ concentration 
can be generated by Ca2+ release from intracellular stores or by Ca2+ influx. Typically, 
the former is maintained for only a very short time (seconds), while the latter may be 
sustained much longer (Gebicke-Haerter, 2001). The sustained elevation of intracellular 
Ca2+ caused by HOCl signified that the elevation might be generated by Ca2+ influx as 
both EGTA and nifedipine can attenuate cell death. At the same time, intracellular Ca2+ 
channel antagonists (dantrolene and flufenamic acid) also completely reversed cell death 
induced by HOCl. Therefore, HOCl might induce intracellular Ca2+ elevation through 
release from intracellular stores and Ca2+ influx. Stimuli affect Ca2+ elevations by both 
mechanisms have been demonstrated in microglia treated with C5a and C3a complement 
fragments (Moller et al., 1997). Consequently, the Ca2+-dependent scramblase could be 
activated in cytoplasm and cause an increasing externalisation of PS.  
Besides calpain activation, contribution of lysosomal pathway to HOCl-mediated 
neuronal apoptosis was also suggested by DNA microarray analysis in which the mRNA 
levels of cathepsins B, S and Z were induced several folds. In addition, AO uptake assay 
and cathepsin inhibitors revealed that calpain activation might lead to lysosomal rupture 
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and the release of cathepsins particularly cathepsins D and L as their inhibition 
completely prevented cell death. The observation is consistent with other studies which 
demonstrated that aspartyl cathepsin D participates in apoptosis induced by oxidative 
stress (Nilsson et al., 1997; Roberg and Ollinger, 1998; Roberg et al., 1999a). Calpain 
activation can lead to rupture of lysosomes (Yamashima et al., 2003) and cathepsins that 
released can function independently from caspases (Broker et al., 2004). Although the 
expression of cathepsin B and S was enhanced, their inhibitors do not rescue the cells 
from death. Felbor and coworkers (2002) demonstrated a pivotal role for cathepsins B 
and L in maintenance of the CNS because cathepsin B-/-/L-/- mice reveal neuronal loss 
and brain atrophy. Therefore, the upregulation of cathepsins B, S and Z might be 
neuroprotective.  
The lack of activation of caspase in this apoptosis model can be explained by 
several factors. Since neurons contain lower intracellular glutathione than other cell 
types, this might render caspases to inactivation due to oxidation of its active site thiol 
group (Hampton and Orrenius, 1997; Hampton et al., 1998a; Chandra et al., 2000). H2O2 
and the thiol reagent thiuram disulfide have been shown to affect caspase activity and 
processing by a thiol-dependent mechanism (Hampton and Orrenius, 1997; Nobel et al., 
1997). Ishihara and co-workers (2005) further demonstrated that oxidized form of pro-
caspase-3 is increased under oxidative stress. In addition, the formation of apoptosome 
might be inhibited in the presence of HOCl. Recently, the physiological role of the lysine 
residues of cytchrome c has been linked to its pro-apoptotic activity and post-translational 
modification of lysine residue of yeast isocytochrome c results in a low affinity for 
apoptosis protease-activating factor-1 (Apaf-1) and consequently inability to trigger 
caspase activation (Kluck et al., 2000). A previous study has shown that HOCl induces 
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oxidation of cytochrome c at lysine residues (Chen et al., 2004). Thus, HOCl could 
potentially prevent caspase activation by oxidative modification of the lysine residue of 
cytochrome c. Also, calpains have been shown to cleave several apoptosis regulatory 
proteins including Apaf-1 (Reimertz et al., 2001) and leading to inhibition of apoptosome 
formation. Furthermore, calpains can cleave the caspases and thereby hamper their 
processing into the active form. This has been demonstrated in NMDA and 3-
nitropropionic acid-induced injury where calpains negatively regulate caspase-3/9 
activation and lead to caspase-independent neuronal death (Lankiewicz et al., 2000; Bizat 
et al., 2003). Therefore, calpains can influence apoptotic pathways at different steps by 
blocking activation of the caspase cascade and activating other caspase-independent cell 
death pathways. However, the role of these mediators in HOCl-induced neuronal 
apoptosis remains to be elucidated.  
Same as caspase, calpain and cathepsin are also thiol-proteases that require a 
reduced cysteine residue within their catalytic triad for full activity (Guttman et al., 1997). 
Their activity can be modulated by redox state, characterized by decreased activity, in 
vitro and in situ, in the presence of oxidants (Lal et al., 1975; Guttman et al., 1997, 1998; 
McCollum et al., 2004). Interestingly, their activity is not inhibited in increased oxidative 
stress caused by HOCl. This discrepancy can be hypothesized that increased intracellular 
calcium after admission of HOCl leads to the autolysis of calpain with its active site still 
buried within the protein structure and inaccessible to oxidants or free radicals (Guttman 
et al., 1998). However, its proteolytic activity, which resulting in exposure of the active 
site, is reduced. Thus, cleavage of α-fodrin is not detectable within the first few hours 
after treatment of HOCl. After the cellular environment becomes sufficiently reduced to 
allow substantial calpain-mediated proteolytic activity, rapid degradation occurs because 
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calpain has been fully autolyzed to the form with the highest activity, which subsequently 
leads to cell damage.  
Here, another question arises if HOCl causes cell death by acidosis? HOCl is a 
weak acid (pKa 7.5) (Morris, 1966), as such HOCl will not alter the pH of buffer so 
HOCl-induced cellular acidosis can be ruled out. Because of its high reactivity, HOCl 
disappear rapidly in multiple reactions with available substrates. The very fast reaction of 
HOCl with thiols proposed that these would be major cell targets (Pullar et al., 2000). For 
example, the function of Ca2+-ATPase and Na+-K+-ATPase, which is thiol-dependent, is 
impaired by HOCl (Kukreja et al., 1990; Eley et al., 1991; Kato et al., 1998; Pullar et al., 
2000). These data suggest that, HOCl might rapidly react with cellular targets that may 
trigger a death program. In view of this, redox-sensitive calcium ion channels such as 
RyR, IP3R and L-type calcium channel is believed to be activated by HOCl as oxidizing 
conditions favour channels opening (Bootman et al., 1992; Annunziato et al., 2002; 
Waring, 2005). As a result, HOCl facilitates calcium release from ER store as well as 
calcium influx through L-type calcium channel. Thus, intracellular calcium elevations 
could have different effects according to their absolute entity: moderate increases could 
be neuroprotective while pronounced elevations appear to be neurotoxic (Annunziato et 
al., 2002). As such, by inhibiting anyone of them HOCl-induced apoptosis can be 
reversed completely. Changes in calcium homeostasis may lead to mitochondrial 
dysfunction due to the opening of mitochondrial transition pores. Elevated intracellular 
calcium levels can affect transcriptional activity of several genes.   
            Taken together, HOCl-induced apoptosis is independent from caspase activation, 
rather it causes increase calcium concentration (probably by oxidazing the calcium 
channels) which in turn leads to calpain activation and downstream lysosomal rupture 
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and release of cathepsins. On the other hands, elevated calcium level can induce gene 
expression of Nr4a1, a nuclear orphan receptor, which is capable of transmitting the 
apoptotic signal from the nucleus to the mitochondria. Finally, cleavage of cellular 
substrates and disruption of cellular architecture by activating proteases as well as 






































Figure 6.1: Schematic representation of the mechanism of HOCl-mediated neuronal 
apoptosis.  
 
Our results indicate that HOCl-induced apoptosis in cortical neurons was triggered by 
elevated intracellular calcium level as a consequence of oxidazing redox-sensitive 
calcium channels. Activation of calcium-dependent proteases, calpains, can cause 
lysosomal rupture and concomitant release of cathepsins. On the other hand, calcium-
induced expression of Nr4a1, which translocates to mitochondria induces nuclear 
translocation of the proapoptotic factors from mitochondria. Due to cleavage of cellular 
























6.4 HOCl-induced cellular adaptation at gene expression level 
6.4.1 Suppression of cell cycle genes 
For over a decade, evidence has mounted that nerve cell death in the CNS is often 
intimately linked to deregulation of the cell cycle. Mitotic markers appear in neurons at 
risk for death in a variety of neurodegenerative conditions, in mouse and in humans 
(Jordan-Sciutto et al., 2002; Love, 2003; Ranganathan and Bowser, 2003). Studies have 
shown that experimentally driving the cell cycle in a mature neurons leads to cell death 
rather than cell division (al-Ubaidi et al., 1992; Feddersen et al., 1992), and blocking cell-
cycle initiation can prevent many types of neuronal cell death (Park et al., 1996, 1997). 
However, cell cycle re-entry is not an obligatory step in the apoptotic pathway as almost 
all of the cell cycle genes were down-regulated in HOCl-treated neurons. In line with 
present study, cortical neuronal apoptosis caused by oxidative stress was also not 
accompanied by any evidence of attempted cell cycle re-entry as Cdks and cyclins are not 
up-regulated (Langley and Ratan, 2004). Cell cycle genes repression in this case might be 
beneficial to neurons since the usage of pharmacological Cdk inhibitors and the 
expression of Cdk inhibitors or dominant-negative Cdks can protect neurons from death 
(Park et al., 1997; Jorda et al., 2003; Johnson et al., 2005). Further, senescent cells with 
downregulated positive-acting cell cycle regulatory genes were resistant to apoptosis and 
were associated with increased Bcl-2 expression (Wang, 1995; Park et al., 1996).  
6.4.2 Induction of Nrf2-ARE pathway (namely programmed cell life pathway) 
Genes related to GSH biosynthesis and NADPH-producing process induced in the 
presence of HOCl acts as a cellular defense mechanism. During oxidative stress, increased 
NADP+ concentration will lead to activation of glucose-6-phosphate dehydrogenase, 
enzyme that catalyses the first rate-limiting step in the oxidative branch of PPP, and 
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subsequently stimulation of PPP (Spolarics et al., 1996; Ursini et al., 1997). Studies have 
showed that stimulation of PPP in neurons and astrocytes conferred protection against 
H2O2 toxicity by producing NADPH (Kletzien et al., 1994; Ben-Yoseph et al., 1996; 
Kussmaul et al., 1999; Salvemini et al., 1999). The induction of other detoxification 
enzymes such as Gst, Nqo1, Aldh, and Dhrs8 are important in detoxifying quinines and 
maintaining the cellular redox balance. One common feature of these proteins is that they 
use GSH and NADPH as co-factor. So, for efficient detoxification and maintenance of 
cellular redox status, it would be beneficial to increase these proteins together with GSH 
and NADPH.  
Other than antioxidant genes, HSPs genes were also regulated in a GSH-dependent 
manner (Calabrese et al., 2003). Fratelli et al. (2005) showed that HSP40 and HSP70 are 
strongly induced by GSH depletion. The induction of HSPs upon exposure to 
environmental insults constitutes the most ubiquitous and evolutionarily conserved stress 
response known to the living world. HSP function as molecular chaperones aiding in the 
assembly, folding, and translocation of various other proteins throughout the cells, and 
their induction during stress is believed to be important for preventing misfolding and 
aggregation, as well as for facilitating refolding and removal of damaged proteins. 
Elevations in HSP expression have been shown to enhance survival of cells and prevent 
apoptosis during a wide variety of stress conditions (Creagh et al., 2000; Jolly and 
Morimoto, 2000) through suppression of other apoptotic signaling pathways (Gabai et al., 
1997; Park et al., 2001). In addition, elevated HSP expression not only improves cell 
survival, but also reduces the oxidative damage to proteins, DNA, and lipids (Park et al., 
1998; Su et al., 1999; Yamamoto et al., 2000) by decreasing the intracellular level of ROS 
via maintaining GSH content (Arrigo, 1998; Baek et al., 2000).  
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Altogether, the upregulation of detoxification enzymes, antioxidant proteins and 
HSPs is due to the activation of antioxidant response element (ARE) found in their 
promoters followed alteration of thiol redox state (Wasserman and Fahl, 1997; Dickinson 
et al., 2004; Iles and Liu, 2005). Under conditions of oxidative stress, transcription factor 
NF-E2-related factor-2 (Nrf2) will release from its sequestration, translocates into the 
nucleus and binds to ARE sequence, leading to transcriptional activation of antioxidant 
enzymes and HSP (Itoh et al., 1999a,b; Wild et al., 1999; Hayes et al., 2000; Ishii et al., 
2000; Nguyen et al., 2000; Chanas et al., 2002). This is termed Nrf2-ARE pathway 
(namely programmed cell life pathway) (Li et al., 2002) which protecting cells from 
oxidative stress via the coordinate up-regulation of several genes to achieve synergistic 
effect in the maintenance of GSH levels as well as detoxification of reactive 
intermediates. 
6.4.3 Energy salvage 
HOCl has been shown to inhibit glucose uptake, glyceraldehyde-3-phosphate 
dehydrogenase, lactate dehydrogenase, hexokinase, creatine kinase, α-ketoglutarate 
dehydrogenase complex and mitochondrial respiration in intact cells as a result of 
decrease in GSH availability (Schraufstätter et al., 1990; Eley et al., 1991; Pullar et al., 
1999; Jha et al., 2000; Jeitner et al., 2005). These inhibitions of electron transport chain 
and tricarboxylic acid cycle inevitably derange energy metabolism resulting in a 
precipitous decrease in intracellular concentrations of ATP and NAD (Pullar et al., 1999). 
Suppression of protein and lipid synthesis, two highly energy-dependent processes, was 
also found in HOCl-treated brain slices (Krasowska and Konat, 2004). Consistently, ATP 
depletion and concomitantly up-regulated glycolytic enzymes, down-regulation of 
cellular metabolism and ATP utilization, such as reduction of genes involved in organic 
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acid as well as lipid metabolism, and decrease of mRNA expression of proteins 
associated with ATP-dependent transportation and signal transduction were observed in 
HOCl-treated neurons. Oxidative stress has been reported to induce a marked increase in 
glycolytic genes owing to the regulation of redox-sensitive transcription factor, hypoxia 
inducible factor-1 (Ito et al., 1996; Moyes and LeMoine, 2005). Glycolysis can help to 
produce energy under low flux conditions for maintenance of cell functions. Study using 
the exogenously added glucose completely abolished the glutamate-mediated increase in 
apoptotic neurons, and elicited full protection against neuronal ATP depletion (Delgado-
Esteban et al., 2000). ATP that synthesized from glycolysis via membrane-associated 
glycolytic enzymes can rapidly be used by ‘pump’ that found juxtaposed (Ronquist and 
Waldenstrom, 2003).  
Decreasing energy demand as a result of oxidative stress and the dependence of 
glycolysis takes on additional importance if there are impairments in the function of key 
components of oxidative metabolism, which can result in the increase production of ROS 
(Blass et al., 2000). As such, generation of ROS associated with formation of 
intracellular ATP through oxidative phosphorylation can be eliminated. By reducing the 
rate of ROS generation, normal cellular antioxidant defenses, repair enzymes, and 
degradative pathways have the potential to maintain normal cellular function by 
minimizing the accumulation of oxidized proteins and the associated formation of protein 
aggregates that can lead to protein aggregation. Consistent with this concept, 30-40% 
increases in life span and corresponding decreases in age-related diseases are associated 
with caloric restriction in mammals that correlate with a reduction in basal energy 
metabolism (Blanc et al., 2003; Hursting et al., 2003). Thus, a decrease in metabolic rate 
and the associated generation of ROS appears to be critical to the maintenance of cell 
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function during oxidative stress. The glycolytic pathway also serves purposes beyond 
energy production. Glycolytic intermediates are needed in the PPP for the production of 
NADPH. On one hand, the glycolysis seems to be protective. On the other hand, 
glycolysis can favour apoptosis, which in general is an energy-requiring process (Colussi 
et al., 2000).  
 
6.5 Drawbacks of current study 
           Although treatment in EBSS eliminates the confounding observation caused by 
chloramines formed when HOCl is added to the medium, cellular cytotoxicity mediated 
by HOCl due at least in part to intermediates derived from the reaction of HOCl with 
intracellular constituents such as chloramines, chlorohydrins, or protein carbonyl 
moieties (Winterbourn, 2002) was unable to rule out. Experiments with antioxidants to 
inhibit HOCl-mediated chloramines formation or lipid peroxidation are precluded 
because they will also “scavenge” HOCl.  
Owing to its characteristic spectral changes when bound to acidic structures or 
present in acidic compartments, AO has been used in histology to stain nucleic acids, 
chromatin, and lysosomes. Theoretically, mitochondria as an acidic organelle should also 
be stained by AO. Moreover, the participation of mitochondria in HOCl mediated 
apoptosis has been reported in liver cells (Whiteman et al., 2005). In addition, ATP 
depletion in cortical neurons caused by HOCl also reflects mitochondrial proton gradient 
dissipitation. Therefore, AO staining alone is not enough to support the notion that 
rupture of lysosomal membrane is indeed occurred after HOCl treatment. To further 
confirm the lysosomal rupture, translocation of lysosome-specific enzyme for instance β-
hexosaminidase to cytosol will need to include in further study. One must also bear in 
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mind that the result obtained from the use of cathepsin inhibitors can be very confusing 
as they can interact with other unidentified protease (Bogyo et al., 2000). 
Although microarray analysis allows many different classes of genes to study 
simultaneously, the quantity of information obtained for each experiment can be 
overwhelming. Second, the categorization of genes into groups by similarity of function 
based on published literature was limited because it ignored poorly described genes and 
expressed sequence tags (ESTs). Furthermore, not all genes are included on the 
MG_U74A gene chip. Thus, the list of changes in gene expression in this report should 
be considered incomplete.  
 
6.6 Concluding remarks and future directions 
Currently there is sufficient documentation to place oxidative and nitrative 
processes in the center of the pathogenic mechanism that leads to neuronal loss. 
Therefore, HOCl as an oxidant related to both oxidative and nitrative procceses deserves 
more attention in the study of neurodegenerative diseases. The current study provides 
insight into the involvement of molecular targets such as calpains, cathepsin proteases, 
and many other apoptotic genes in HOCl-mediated neuronal apoptosis. Their 
participation in the neurotoxicity of HOCl enables them to be targeted for multiple 
disorders which HOCl is found associated. However, some of their functions have not yet 
been reported in neurodegenerative disorders such as Nr4a1. Further studies of their 
normal function, role in disease pathogenesis, and contribution to other pathways, are 
required in order to increase the success rate of newly identified pharmacological 
compounds. Potential defences against the toxicity of HOCl for instance the induction of 
phase II detoxification enzymes, GSH biosynthesis, NADPH-generating metabolic 
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pathway, and HSPs and repression of cell cycle proteins as well as ATP-dependent 
processes have also been discovered via microarray analysis. However, all these 
responses are considerably low in neurons. Given that, strategies to boost the defensive 
gene expression would be useful in reducing neuronal vulnerability to oxidative stress.  
Overall, our study have provided the first insight into the role of this oxidant in 
neuronal cell death, which in turn may present valuable information to the understanding 
of the development of neurodegenerative diseases such as AD and the identification of 
cellular defensive mechanisms as revealed by microarray may ultimately serve to 
elucidate robust therapeutic strategies against neurodegenerative disorders and allow 
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